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FOREWORD
The Superfund Amendments and Reauthorization Act (SARA) of 1986
(Public Law 99-499) extended and amended the Comprehensive Environmental
Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund).
This public law directed the Agency for Toxic Substances and Disease
Registry (ATSDR) to prepare toxicological profiles for hazardous
substances which are most commonly found at facilities on the CERCLA
National Priorities List and which pose the most significant potential
threat to human health, as determined by ATSDR and the Environmental
Protection Agency (EPA). The lists of the 250 most significant
hazardous substances were published in the Federal Register on April 17,
1987; on October 20, 1988; on October 26, 1989; and on October 17, 1990.
A revised list of 275 substances was published on October 17, 1991.
Section 104(i)(3) of CERCLA, as amended, directs the Administrator
of ATSDR to prepare a toxicological profile for each substance on the
lists. Each profile must include the following content:
(A) An examination, summary, and interpretation of available
toxicological information and epidemiological evaluations on the
hazardous substance in order to ascertain the levels of significant
human exposure for the substance and the associated acute,
subacute, and chronic health effects.
(B) A determination of whether adequate information on the health
effects of each substance is available or in the process of
development to determine levels of exposure which present a
significant risk to human health of acute, subacute, and chronic
health effects.
(C) Where appropriate, an identification of toxicological testing
needed to identify the types or levels of exposure that may present
significant risk of adverse health effects in humans.
This toxicological profile is prepared in accordance with
guidelines developed by ATSDR and EPA. The original guidelines were
published in the Federal Register on April 17, 1987. Each profile will
be revised and republished as necessary.
The ATSDR toxicological profile is intended to characterize
succinctly the toxicological and adverse health effects information for
the hazardous substance being described. Each profile identifies and
reviews the key literature (that has been peer-reviewed) that describes
a hazardous substance's toxicological properties. Other pertinent
literature is also presented but described in less detail than the key
studies. The profile is not intended to be an exhaustive document;
however, more comprehensive sources of specialty information are
referenced.









11. PUBLIC HEALTH STATEMENT
This Statement was prepared to give you information about
1,2,3-trichloropropane and to emphasize the human health effects that may
result from exposure to it. The Environmental Protection Agency (EPA) has
identified 1,300 National Priorities List (NPL) sites. 1,2,3-Trichloropropane
has been found at 8 of these sites. However, we do not know how many of the
1,300 NPL sites have been evaluated for 1,2,3-trichloropropane. As EPA
evaluates more sites, the number of sites at which 1,2,3-trichloropropane is
found may change. The information is important for you because
1,2,3-trichloropropane may cause harmful health effects and because these
sites are potential or actual sources of human exposure to
1,2,3-trichloropropane.
When a chemical is released from a large area such as an industrial
plant, or from a container such as a drum or bottle, it enters the environment
as a chemical emission. This emission, which is also called a release, does
not always lead to exposure. You can be exposed to a chemical only when you
come into contact with the chemical. You may be exposed to it in the
environment by breathing, eating, or drinking substances containing the
chemical, or from skin contact with it.
If you are exposed to a hazardous substance such as 1,2,3-trichloropropane,
several factors will determine whether harmful health effects will
occur and what the type and severity of those health effects will be. These
factors include the dose (how much), the duration (how long), the route or
pathway by which you are exposed (breathing, eating, drinking, or skin
contact), the other chemicals to which you are exposed, and your individual
characteristics such as age, sex, nutritional status, family traits, life
style, and state of health.
1.1 WHAT IS 1,2,3-TRICHLOROPROPANE?
1,2,3-Trichloropropane is a colorless, heavy liquid with a sweet but
strong odor. It evaporates almost as fast as water does at normal
temperatures. Small amounts of 1,2,3-trichloropropane will dissolve in water.
1,2,3-Trichloropropane can dissolve several substances, such as oils and
waxes, the way water dissolves salt. For this reason, it has been and may
continue to be used as an industrial solvent, paint remover, and cleaner. We
do not know exactly how much of it is made or used now, but it may be a large
amount. Most of the 1,2,3-trichloropropane is used to make other substances.
In sunlight, 1,2,3-trichloropropane in the air will break down. Most of
the 1,2,3-trichloropropane that is released to the air will disappear in a
month. In water, half of it will evaporate into the air within hours or
several days. Very little of it will stick to the soil at the bottom of
rivers, lakes, or ponds, and very little of it will be expected to concentrate
in fish or other seafoods. 1,2,3-Trichloropropane will not stick to soil. If
it is spilled onto most soils, some will evaporate and some will travel
through the soil into the groundwater, where it may stay for a long time. It
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may slowly change to a simpler form in water and soil by natural biological
and chemical processes.
You will find more information on the properties of 1,2,3-trichloropropane
in Chapters 3, 4, and 5.
1.2 HOW MIGHT I BE EXPOSED TO 1,2,3-TRICHLOROPROPANE?
If you live near a hazardous waste disposal site in which
1,2,3-trichloropropane is not stored properly, you could be exposed to
1,2,3-trichloropropane from breathing air or drinking water. Because
1,2,3-trichloropropane easily changes into a vapor, you are more likely to be
exposed from breathing air than from drinking water. A child playing in this
waste disposal site could be exposed by drinking liquids containing
1,2,3-trichloropropane, by eating soil coated with 1,2,3-trichloropropane, or
getting this soil or liquid on his or her skin.
You could be exposed to 1,2,3-trichloropropane in other ways that have
nothing to do with hazardous waste sites. For example, you may be exposed to
higher levels of 1,2,3-trichloropropane if you are using paint- and varnish-
removers that contain it; however, some of these products may no longer
contain this chemical. If you breathe air near an accidental spill of
1,2,3-trichloropropane, you can be exposed to higher levels of the chemical.
Exposure in the workplace may result from spills or other accidents or from
normal operations in the workplace.
1,2,3-Trichloropropane is not common in the environment (air, water, and
soil), but it has been found in a few rivers, bays, drinking water,
groundwater, and hazardous waste sites at low levels. This is because
1,2,3-trichloropropane can enter the environment while it is being made, where
it is used to make or to dissolve other substances, or where it is released in
the waste that is made during these processes. Although 1,2,3-trichloropropane
is usually not found in the environment, disposal at hazardous waste
sites in the past, or release during spills and accidents have lead to higher
levels in nearby water, soil, and groundwater. Although we do not know
exactly how much 1,2,3-trichloropropane the general public or workers are
exposed to, the information that we have shows that the levels are probably
low and exposure probably does not occur often.
You can find more information in Chapter 5 on how much 1,2,3-
trichloropropane is in the environment and how you can be exposed to it.
1.3 HOW CAN 1,2,3-TRICHLOROPROPANE ENTER AND LEAVE MY BODY?
If you were to drink water containing 1,2,3-trichloropropane, most of
the chemical would pass into your body from your stomach and intestines within
the same day. 1,2,3-trichloropropane would also pass into your body from your
lungs if you were to breathe in air containing it or from your skin if you
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were to touch it. However, we do not know how quickly or completely
1,2,3-trichloropropane passes into your body from your lungs or skin.
1,2,3-Trichloropropane that enters your body leaves your body almost
completely within a few days in your breath, urine, and feces. More
information on how 1,2,3-trichloropropane can enter and leave your body is
presented in Chapter 2.
1.4 HOW CAN 1,2,3-TRICHLOROPROPANE AFFECT MY HEALTH?
Some people who breathed air containing high levels of 1,2,3-
trichloropropane for several minutes had eye and throat irritation. These levels
of 1,2,3-trichloropropane are ikely to be much higher than levels usually found
in outdoor air, including air at hazardous waste sites. We do not know what
effects might occur in people who breath 1,2,3-trichloropropane for days,
weeks, or longer durations. We also do not know the possible effects of
1,2,3-trichloropropane in people who swallow 1,2,3-trichloropropane or get
1,2,3-trichloropropane on their skin.
Animals that breathed air containing 1,2,3-trichloropropane at levels
higher than those usually found in the environment developed other health
effects. Rats and mice died after they breathed air containing high levels of
1,2,3-trichloropropane for several hours, but we do not know the exact cause
of death. These levels of 1,2,3-trichloropropane are several times higher
than those that can cause eye and throat irritation in humans. Rats that
breathed 1,2,3-trichloropropane for a few months at levels lower than those
that affected humans developed eye, nose, and lung irritation and liver and
kidney disease.
Rats and mice usually died from damage to the liver and kidney within a
few days after they swallowed a large amount of 1,2,3-trichloropropane. Most
rats and mice that swallowed small amounts of 1,2,3-trichloropropane every day
for a few months also died from liver and kidney damage. Rats that swallowed
even smaller amounts of 1,2,3-trichloropropane every day for a few months did
not die but developed stomach irritation, blood disorders, and minor liver and
kidney damage.
Rabbits had severe skin irritation and even injury to internal organs,
including the liver, kidneys, and stomach after 1,2,3-trichloropropane was
applied to their skin in large amounts for 1 day. These injuries can result
in death. 1,2,3-Trichloropropane also caused eye irritation in rabbits and
rats when it was applied to the eyes.
We have limited knowledge of the effects in animals exposed to very
small amounts of 1,2,3-trichloropropane by breathing, swallowing, or skin
contact for many months or years leads to serious disease or death. Rats that
breathed low levels of 1,2,3-trichloropropane for several weeks or swallowed
large amounts of 1,2,3-trichloropropane for a few days did not develop
fertility problems, but we do not know whether breathing high levels of
41. PUBLIC HEALTH STATEMENT
1,2,3-trichloropropane or swallowing 1,2,3-trichloropropane for more than a
few days affects fertility in animals. 1,2,3-Trichloropropane has not been
found to cause birth defects when injected in rats. We do not know whether
1,2,3-trichloropropane causes cancer in humans, but animals that swallowed low
doses of 1,2,3-trichloropropane for most of their lives developed cancer in a
number of organs.
More information on how 1,2,3-trichloropropane can affect health can be
found in Chapter 2.
1.5 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO
1,2,3-TRICHLOROPROPANE?
Scientists can measure 1,2,3-trichloropropane in blood, urine, and
breath, but there are no readily available tests to determine whether you have
been exposed. We do not think these tests would be adequate to allow doctors
to predict harmful health effects. More information about tests for exposure
and effects can be found in Chapters 2 and 6.
1.6 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO PROTECT HUMAN HEALTH?
The federal government has a rule designed to protect workers who may be
exposed to 1,2,3-trichloropropane. The Occupational Safety and Health
Administration (OSHA) states that workers may not be exposed to average levels
of 1,2,3-trichloropropane greater than 10 ppm in air during an 8-hour workday.
The federal government has no recommendations on environmental exposure to
1,2,3-trichloropropane. More information on regulations and advisories can be
found in Chapter 7.
1.7 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns not covered here, please
contact your state health or environmental department or:
Agency for Toxic Substances and Disease Registry
Division of Toxicology
1600 Clifton Road, E-29
Atlanta, Georgia 30333
This agency can also provide you with information on the location of the
nearest occupational and environmental health clinic. Such clinics specialize
in recognizing, evaluating, and treating illnesses that result from exposure
to hazardous substances.
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2.1 INTRODUCTION
The primary purpose of this chapter is to provide public health
officials, physicians, toxicologists, and other interested individuals and
groups with an overall perspective of the toxicology of 1,2,3-trichloropropane
and a depiction of significant exposure levels associated with various adverse
health effects. It contains descriptions and evaluations of studies and
presents levels of significant exposure for 1,2,3-trichloropropane based on
toxicological studies and epidemiological investigations.
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals address the needs of persons living
or working near hazardous waste sites, the information in this section is
organized first by route of exposure--inhalation, oral, and dermal--and then
by health effect--death, systemic, immunological, neurological, developmental,
reproductive, genotoxic, and carcinogenic effects. These data are discussed .
in terms of three exposure periods- -acute (less than 15 days), intermediate
(15-364 days), and chronic (more than 365 days).
Levels of significant exposure for each route and duration are presented
in Tables 2-1, 2-2 and 2-3 and illustrated in Figures 2-1 and 2-2. The points
in the figures showing no-observed-adverse-effect levels (NOAELS) or lowest-
observed-adverse-effect levels (LOAELS) reflect the actual doses (levels of
exposure) used in the studies. LOAELs have been classified into "less
serious" or "serious" effects. These distinctions are intended to help the
users of the document identify the levels of exposure at which adverse health
effects start to appear. They should also help to determine whether or not
the effects vary with dose and/or duration, and place into perspective the
possible significance of these effects to human health.
The significance of the exposure levels shown in the tables and figures
may differ depending on the user's perspective. For example, physicians
concerned with the interpretation of clinical findings in exposed persons may
be interested in levels of exposure associated with “serious" effects. Public
health officials and project managers concerned with appropriate actions to
take at hazardous waste sites may want information on levels of exposure
associated with more subtle effects in humans or animals (LOAEL) or exposure
levels below which no adverse effects (NOAEL) have been observed. Estimates
of levels posing minimal risk to humans (Minimal Risk Levels, MRLs) may be of
interest to health professionals and citizens alike.
Estimates of exposure levels posing minimal risk to humans (MRLs) have
been made, where data were believed reliable, for the most sensitive noncancer
effect for each exposure duration. MRLs include adjustments to reflect human
variability from laboratory animal data to humans.
62. HEALTH EFFECTS
Although methods have been established to derive these levels (Barnes et
al. 1988; EPA 1989a), uncertainties are associated with these techniques.
Furthermore, ATSDR acknowledges additional uncertainties inherent in the
application of the procedures to derive less than lifetime MRLs. As an
example, acute inhalation MRLs may not be protective for health effects that
are delayed in development or are acquired following repeated acute insults,
such as hypersensitivity reactions, asthma, or chronic bronchitis. As these
kinds of health effects data become available and methods to assess levels of
significant human exposure improve, these MRLs will be revised.
2.2.1 Inhalation Exposure
2.2.1.1 Death
No studies were located regarding death in humans after inhalation
exposure to 1,2,3-trichloropropane.
Exposure to 1,2,3-trichloropropane of unknown purity for 4-6 hours
caused death in mice at concentrations as low as 343 ppm (Gushow and Quast
1984) and rats at concentrations as low as 500 ppm (Union Carbide 1958). An
intermediate-duration study showed that intermittent exposure to 297 ppm and
higher concentrations of 1,2,3-trichloropropane for 4 weeks was lethal in rats
(Johannsen et al. 1988). The available data suggest that 1,2,3-trichloropropane
concentrations producing death in rodents may be similar (i.e.,
approximately 300 ppm) for acute- and intermediate-duration exposures of
several weeks. The cause of death is unclear, but signs suggestive of central
nervous system (CNS) impairment (e.g., incoordination and convulsions) have
been observed prior to death in both species. The highest NOAEL values and
all reliable LOAEL values for death in both species and duration categories
are recorded in Table 2-l and plotted in Figure 2-1.
2.2.1.2 Systemic Effects ,
Systemic effects of inhaled 1,2,3-trichloropropane are discussed below.
The highest NOAEL values and all reliable LOAEL values for these effects in
each species and duration category are recorded in Table 2-1 and plotted in
Figure 2-l.
Respiratory Effects. Limited information indicates that brief exposure
(15 minutes) to 100 ppm 1,2,3-trichloropropane (purity unknown) can cause
throat irritation in humans (Silverman et al. 1946).
Repeated exposure of animals to 1,2,3-trichloropropane concentrations
much lower than 100 ppm causes respiratory system effects that are indicative
of irritant action. Intermittent 4-hour exposures for 11 days produced
alterations in nasal tissues of rats and mice, particularly of the olfactory
epithelium (Miller et al. 1986a, 1986b). These changes included decreased
thickness of the olfactory epithelium in rats at 3 ppm, degeneration of the
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olfactory epithelium in rats at 10 ppm and higher concentrations, and
inflammation and decreased thickness of the olfactory epithelium in mice at
lo-13 ppm with degeneration at higher concentrations. Based on the NOAEL of
1 ppm for these effects in rats, an acute inhalation MEL of 0.0003 ppm was
calculated as described in the footnote in Table 2-l. Intermittent exposure
to slightly higher concentrations of 1,2,3-trichloropropane (4.5 ppm) or more
for 13 weeks caused focal peribronchial hyperplasia in rats (Johannsen et al.
1988). Intermittent exposure to 132 ppm for 11 days caused nasal submucosal
fibrosis in rats (Miller et al. 1986a).
Cardiovascular Effects. No studies were located regarding
cardiovascular effects in humans after inhalation exposure to
1,2,3-trichloropropane.
There were no histopathological changes in the hearts of rats and mice
that were intermittently exposed to concentrations as high as 132 ppm
1,2,3-trichloropropane for 11 days (Miller et al. 1986a) or rats that were
similarly exposed to up to 49 ppm 1,2,3-trichloropropane for 13 weeks
(Johannsen et al. 1988).
Gastrointestinal Effects. No studies were located regarding
gastrointestinal effects in humans after inhalation exposure to
1,2,3-trichloropropane.
There were no histopathological changes in the stomach and intestines of
rats and mice that were intermittently exposed to concentrations as high as
132 ppm 1,2,3-trichloropropane for 11 days (Miller et al. 1986a) or rats that
were similarly exposed to up to 49 ppm 1,2,3-trichloropropane for 13 weeks
(Johannsen et al. 1988).
Hematological Effects. No studies were located regarding hematological
effects in humans after inhalation exposure to 1,2,3-trichloropropane.
Hematological evaluations were normal in rats and mice that were
intermittently exposed to concentrations as high as 132 ppm
1,2,3-trichloropropane for 11 days (Miller et al. 1986a). Hematological
evaluations of rats that were similarly exposed to up to 49 ppm
1,2,3-trichloropropane for 13 weeks also were normal, but splenic
hematopoiesis was increased at 4.5 ppm or more (Johannsen et al. 1988).
Although increased splenic hematopoiesis was observed, other hematology
parameters were unremarkable. Spleen weights were decreased in rats that were
intermittently exposed to 579 ppm 1,2,3-trichloropropane for 4 weeks, but the
hematological significance of this effect cannot be determined because
evaluation of hematology and histology was not performed (Johannsen et al.
1988).
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Musculoskeletal Effects. No studies were located regarding
musculoskeletal effects in humans after inhalation exposure to
1,2,3-trichloropropane.
There were no histopathological changes in the skeletal muscle or bone
of rats and mice that were intermittently exposed to concentrations as high as
132 ppm 1,2,3-trichloropropane for 11 days (Miller et al. 1986a) or rats that
were similarly exposed to up to 49 ppm 1,2,3-trichloropropane for 13 weeks
(Johannsen et al. 1988).
Hepatic Effects. No studies were located regarding hepatic effects in
humans after inhalation exposure to 1,2,3-trichloropropane.
Acute and intermediate duration inhalation exposure to
1,2,3-trichloropropane causes increased liver weight in rats and mice.
Increased liver weight was produced by intermittent exposure to 132 ppm for
11 days (Miller et al. 1986a), 95 ppm or more for 4 weeks (Johannsen et al.
1988), and 4.5 ppm or more for 13 weeks (Johannsen et al. 1988). Mild
hepatocellular hypertrophy occurred in most of the rats exposed to 4.5 ppm or
more in the 13-weeks study. Although not accompanied by serious histological
alterations, the increased liver weight may represent an adverse effect
because oral exposure studies (see discussion of Hepatic Effects in
Section 2.2.2.2) indicate that this effect is a manifestation of
1,2,3-trichloropropane-induced hepatotoxicity.
Renal Effects. No studies were located regarding renal effects in
humans after inhalation exposure to 1,2,3-trichloropropane.
Intermittent exposure to 297 ppm or more 1,2,3-trichloropropane for
4 weeks and 49 ppm for 13 weeks caused increased kidney weights without
histopathology in rats (Johannsen et al. 1988). As with liver weight changes,
the increased kidney weight may represent an adverse effect because oral
exposure studies indicate that the increased weight is a manifestation of
1,2,3-trichloropropane-induced nephrotoxicity (see discussion of Renal Effects
in Section 2.2.2.2.).
Dermal/Ocular Effects. Limited information indicates that brief
(15-minute) exposure to 100 ppm 1,2,3-trichloropropane vapor causes eye
irritation in humans (Silverman et al. 1946).
A single 4-hour exposure to vapor concentrations as low as 126 ppm
1,2,3-trichloropropane (Gushow and Quast 1984) caused eye irritation in rats
and mice. Repeated intermittent exposure to vapor concentrations as low as
15 ppm for 13 weeks (Johannsen et al. 1988) caused eye irritation in rats.
Other Systemic Effects. No studies were located regarding other
systemic effects in humans after inhalation exposure to
1,2,3-trichloropropane.
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Intermittent exposure to 1,2,3-trichloropropane concentrations as high
as 132 ppm for 11 days did not adversely affect body weight gain in rats or
mice (Miller et al. 1986a). Body weight gain was decreased in rats that were
intermittently exposed to lethal concentrations (297 ppm or more) of
1,2,3-trichloropropane for 4 weeks and concentrations as low as 15 ppm
1,2,3-trichloropropane for 13 weeks (Johannsen et al. 1988). The decreased
weight gain was more severe at higher concentrations and there was initial
weight loss at 600 ppm in the 4-week study.
2.2.1.3 Immunological Effects
No studies were located regarding immunological effects in humans after
inhalation exposure to 1,2,3-trichloropropane.
There were no histopathological alterations in the thymus, spleen,
lymphoid tissue, or bone marrow of rats and mice that were intermittently
exposed to concentrations as high as 132 ppm 1,2,3-trichloropropane for
11 days (Miller et al. 1986a) or rats that were similarly exposed to up to
49 ppm for 13 weeks (Johannsen et al. 1988). Intermittent exposure to a
higher (lethal) concentration (579 ppm) for 4 weeks caused decreased spleen
weight in rats (Johannsen et al. 1988). Due to the lack of histological
examinations and immunoassays, the immunological significance of the decreased
spleen weight cannot be determined.
2.2.1.4 Neurological Effects
No studies were located regarding neurological effects in humans after
inhalation exposure to 1,2,3-trichloropropane.
No histopathological effects were observed in the brain, spinal cord,
and peripheral nerves of rats and mice that were intermittently exposed to
concentrations as high as 132 ppm 1,2,3-trichloropropane for 11 days (Miller
et al. 1986a). No effect was observed on brain and spinal cord histology and
brain weight in rats that were intermittently exposed to up to 49 ppm for
13 weeks (Johannsen et al. 1988). These data do not necessarily mean that
1,2,3-trichloropropane is not neurotoxic, however, due to a lack of
neurological evaluations. Brain weight was increased in rats exposed to 297
or 579 ppm 1,2,3-trichloropropane for 4 weeks (Johannsen et al., 1988), but it
is unclear if absolute or relative brain weight was increased. The rats in
the 4-week study were hypoactive and had labored breathing, but were not
subjected to histological and neurological evaluations. Due to the lack of
histological and neurological evaluations, signs attributable specifically to
CNS impairment, and sufficient information to determine if relative brain
weight was increased (which could reflect decreased body weight), the
neurological significance of the increased brain weight cannot be determined.
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2.2.1.5 Developmental Effects
No studies were located regarding developmental effects in humans after
inhalation exposure to 1,2,3-trichloropropane.
Limited information regarding developmental effects of inhaled
1,2,3-trichloropropane in animals is available from a reproduction study in
which male and female rats were intermittently exposed to concentrations as
high as 15 ppm prior to mating, during mating, and during gestation (Johannsen
et al. 1988). There were no effects on gestation length, and pup viability
and weight at birth and during lactation were normal. These data incompletely
characterize developmental toxicity because the fetuses were not examined for
teratogenicity.
2.2.1.6 Reproductive Effects
No studies were located regarding reproductive effects in humans after
inhalation exposure to 1,2,3-trichloropropane.
In the only inhalation reproductive study of 1,2,3-trichloropropane,
male and female rats were intermittently exposed to concentrations of
0.49-15 ppm prior to mating, during mating, and during gestation (Johannsen et
al. 1988). There were no effects on mating performance or fertility in either
sex, but the data for the males at 4.5 ppm and higher concentrations are
inconclusive because the control group for these males had low mating
performance compared to another male control group. The highest NOAEL value
is recorded in Table 2-l and plotted in Figure 2-l.
Studies with animals exposed to higher concentrations of
1,2,3-trichloropropane have examined effects on reproductive organs.
Intermittent expcsure to less than or equal to 132 ppm for 11 days (Miller et
al. 1986b) and less than or equal to 49 ppm 1,2,3-trichloropropane for
13 weeks (Johannsen et al. 1988) had no effect on the weights or histology of
the reproductive organs of male and female rats. Intermittent exposure to
1,2,3-trichloropropane for 4 weeks at concentrations that caused some deaths
decreased ovary weights (greater than or equal to 297 ppm) and testes weights
(579 ppm) in rats, but these organs were not examined histologically
(Johannsen et al. 1988). Reproductive function was not evaluated in any of
these studies. Because of incomplete information on reproductive organ
histology and lack of information regarding sperm counts and reproductive
function, conclusions regarding the reproductive toxicity of
1,2,3-trichloropropane cannot be drawn from these studies.
2.2.1.7 Genotoxic Effects
No studies were located regarding genotoxicity in humans or animals
after inhalation exposure to 1,2,3-trichloropropane. Other mutagenicity
studies are discussed in Section 2.4.
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2.2.1.8 Cancer
No studies were located regarding carcinogenicity in humans or animals
after inhalation exposure to 1,2,3-trichloropropane.
2.2.2 Oral Exposure
2.2.2.1 Death
No studies were located regarding death in humans after oral exposure to
1,2,3-trichloropropane.
Oral LD50 values as low as 150 mg/kg have been determined for rats
(Alpert 1982; Smyth et al. 1962). Variations in LD50 .values are apparent,
which could be due to differences in animal strain, sex, fed/fasted state or
compound purity. The cause of death is unclear, but signs suggestive of CNS
impairment (e.g., piloerection, salivation, ataxia, coma) prior to death and
hemorrhagic damage in visceral tissues (e.g., liver, kidney) were observed.
Daily gavage administration of 1,2,3-trichloropropane caused death due to
liver and kidney toxicity in 15% of female rats by the 13th week at a dose of
125 mg/kg, in 100% of female rats by week 2 at 250 mg/kg, and in 80% of female
mice by week 4 at 250 mg/kg (NTP 1983a, 1983b). Mortality occurred at a lower
rate or occurred later in similarly treated male rats and mice. Lethal gavage
doses of 1,2,3-trichloropropane in rodents, therefore, appear to be similar
for acute exposures and intermediate-duration exposures of several weeks.
Doses as high as 149 mg/kg/day were not lethal in rats, however, when
administered in the drinking water for the 13 weeks (Villeneuve et al. 1985).
Although absorption of 1,2,3-trichloropropane from drinking water could have
been decreased due to use of a solubilizer, this suggests that
1,2,3-trichloropropane may be less toxic when ingested gradually throughout
the day than when administered as a bolus. The highest NOAEL values and all
reliable LOAEL values for death for both species and duration categories are
recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.2 Systemic Effects
Systemic effects resulting from oral exposure to 1,2,3-trichloropropane
are discussed below. The highest NOAEL values and all reliable LOAEL values
for these effects in each species and duration category are recorded in
Table 2-2 and plotted in Figure 2-2.
Respiratory Effects. No studies were located regarding respiratory
effects in humans after oral exposure to 1,2,3-trichloropropane.
Two animal studies showed that 1,2,3-trichloropropane produced
pathologic changes in the nasal turbinates of rats and mice when administered
by oral intubation (NTP 1983a, 1983b). These changes were produced by daily
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doses of 250 mg/kg (rats and mice) for 2 weeks and 125 mg/kg (rats) or
250 mg/kg (mice) for up to 17 weeks. Effects were similar in both species;
these typically included inflammation, attenuation of the epithelial lining, '
and necrotic alterations, and principally occurred in the dorsal posterior of
the nasal passages. These effects are similar to those caused by inhalation
exposure to 1,2,3-trichloropropane (see discussion of Respiratory Effects in
Section 2.2.1.2.) The oral doses that produced the nasal alterations were in
the near lethal range. Repeated daily exposure of mice to lower doses of
1,2,3-trichloropropane (as low as 63 mg/kg) by oral intubation over a period
of 17 weeks caused regenerative changes (e.g., hyperplasia) in the bronchiolar
epithelium that did not progress or regress with continued exposure. It is
possible that the nasal and pulmonary effects caused by oral treatment were
due to inadvertent local exposure (see discussion of Systemic Effects in
Section 2.4.) or excretion of 1,2,3-trichloropropane or its metabolites in the
breath (see Section 2.3.4).
Cardiovascular Effects. No studies were located regarding
cardiovascular effects in humans after oral exposure to
1,2,3-trichloropropane.
Two animal studies found that daily administration of
1,2,3-trichloropropane by gavage over a period of 17 weeks caused decreased
heart weight without histological alterations in rats and mice at doses up to
125 and 250 mg/kg, respectively (NTP 1983a, 1983b). This effect is not
considered adverse, due to the lack of histopathology. There was no effect on
heart weight or histology in rats that were administered
1,2,3-trichloropropane in the drinking water at doses as high as 149 mg/kg/day
for 13 weeks (Villeneuve et al. 1985).
Gastrointestinal Effects. No studies were located regarding
gastrointestinal effects in humans after oral exposure to
1,2,3-trichloropropane.
Two animal studies found that daily administration of
1,2,3-trichloropropane over a period of 17 weeks caused gastrointestinal
effects indicative of irritant action, particularly increased hyperkeratosis
and/or acanthosis of the esophagus and stomach (NTP 1983a, 1983b). These
effects occurred at doses of 63 mg/kg/day and higher in mice and 125 mg/kg/day
in rats.
Hematological Effects. No studies were located regarding hematological
effects in humans after oral exposure to 1,2,3-trichloropropane.
One study found evidence of anemia, indicated by decreased hematocrit,
hemoglobin, and erythrocyte counts, in rats that were administered
1,2,3-trichloropropane by gavage at doses as low as 16 mg/kg/day over a period
of 17 weeks (NTP 1983a). The anemia was mild at the lower doses and appears
to be nonregenerative and associated with depressed erythropoiesis. Higher
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doses (63 mg/kg/day or more) in this gavage study produced histological
alterations in the spleen (lymphoid depletion) of rats, and mice similarly
treated with 250 mg/kg/day 1,2,3-trichloropropane had splenic lymphoid
depletion with occasional lymphoid necrosis (NTP 1983b). The hematological
significance of these splenic effects is unknown because hematology was normal
except for the anemia in rats. 1,2,3-Trichloropropane did not produce
significant hematological alterations in rats when administered in the
drinking water at doses as high as 149 mg/kg/day for 13 weeks (Villeneuve et
al. 1985).
Musculoskeletal Effects. No studies were located regarding
musculoskeletal effects in humans after oral exposure to
1,2,3-trichloropropane.
There were no pathological effects in bone or skeletal muscle of rats
and mice that were administered 1,2,3-trichloropropane at doses as high as 125
and 250 mg/kg, respectively, over a period of 17 weeks (NTP 1983a, 1983b).
Hepatic Effects. No studies were located regarding hepatic effects in
humans after oral exposure to 1,2,3-trichloropropane.
Liver toxicity is a major systemic effect of orally administered
1,2,3-trichloropropane in animals. Daily gavage doses of 250 mg/kg produced
hepatotoxicity (e.g., necrosis) severe enough to contribute to death in rats
and mice within 2 weeks (NTP 1983a, 1983b). Necrotic changes also occurred in
the livers of rats and mice treated with daily gavage doses as low as
125 mg/kg over a period of 17 weeks (NTP 1983a, 1983b). Similar doses of
1,2,3-trichloropropane (113 or 149 mg/kg) administered in drinking water for
13 weeks produced mild hepatic changes (e.g., occasional fatty vacuolization
and biliary hyperplasia) in rats (Villeneuve et al., 1985), suggesting that
1,2,3-trichloropropane may be less toxic when ingested gradually throughout
the day than when administered as a bolus. One study found hepatic effects in
rats treated by gavage with doses as low as 16 mg/kg/day over a period of
17 weeks (NTP 1983a). These effects included decreased serum
pseudocholinesterase activity and increased liver weight. It is likely that
the decreased serum pseudocholinesterase activity is attributable to depressed
synthesis resulting from hepatocellular damage, but it could indicate that
1,2,3-trichloropropane inhibits pseudocholinesterase. Based on the NOAEL
(8 mg/kg) for these effects, which is the same as the NOAEL for anemia in rats
(see discussion of Hematologic Effects in Section 2.2.2.2), an intermediate
oral MRL of 0.06 mg/kg/day was calculated as described in a footnote to
Table 2-2.
Renal Effects. No studies were located regarding renal effect in humans
after oral exposure to 1,2,3-trichloropropane.
Kidney toxicity is a major systemic effect of orally administered
1,2,3-trichloropropane in animals. Daily gavage doses of 250 mg/kg produced
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serious renal toxicity (e.g., tubular nephropathy, necrosis) in rats and mice
within 2 weeks (NTP 1983a, 1983b). The kidney damage in rats was severe
enough to contribute to death. Necrotic changes occurred in the kidneys of
rats and mice treated with daily gavage doses as low as 125 mg/kg over a
period of 17 weeks (NTP 1983a, 1983b). Similar doses of
1,2,3-trichloropropane (113 or 149 mg/kg) administered in drinking water for
13 weeks produced mild renal changes (e.g., pyknosis, fine glomular adhesions,
and occasional histologic proteinuria) in rats (Villeneuve et al. 1985). The
term "histologic proteinuria" presumably refers to protein in the lumen of
tubules. The mild renal changes suggest that 1,2,3-trichloropropane may be
less toxic when ingested gradually throughout the day than when administered
as a bolus. Daily gavage doses as high as 60 mg/kg for 2 weeks did not
produce renal histological alterations in rats (Dix 1979), but rats treated
with gavage doses as low as 32 mg/kg/day over a period of 17 weeks displayed
less serious renal effects consisting of increased kidney weight and minimal
inflammation (NTP 1983a).
Dermal/Ocular Effects. No studies were located regarding dermal or
ocular effects in humans after oral exposure to 1,2,3-trichloropropane.
Daily gavage administration of 1,2,3-trichloropropane at doses of
63 mg/kg or more for up to 17 weeks caused alopecia but no gross eye
irritation in rats (NTP 1983a). Mice that were similarly treated with up to
250 mg/kg 1,2,3-trichloropropane had no macroscopic skin lesions or gross eye
irritation (NTP 1983b).
Other Systemic Effects. No studies were located regarding other
systemic effects in humans after oral exposure to 1,2,3-trichloropropane.
Reduced body weight gain occurred in rats treated with
1,2,3-trichloropropane by gavage at doses of 60 mg/kg/day for 2 weeks (Dix
1979) or 63 or 125 mg/kg/day for up to 17 weeks (NTP 1983a). Thyroid
histology, evaluated in the rats treated for up to 17 weeks, was normal.
Doses of 113 or 149 mg/kg/day, when administered in the drinking water for
13 weeks, caused reduced body weight gain and thyroid histological alterations
in rats (Villeneuve et al. 1985). Decreased weight gain without abnormal
thyroid histology occurred in mice that were treated with 250 mg/kg/day by
gavage for up to 17 weeks (NTP 1983b).
2.2.2.3 Immunological Effects
No studies were located regarding immunological effects in humans after
oral exposure to 1,2,3-trichloropropane.
Lymphoid depletion was observed in the spleen and thymus of rats that
were administered 1,2,3-trichloropropane at doses greater than or equal to
63 mg/kg/day over 17 weeks (NTP 1983a). Mice that were similarly treated with
lethal doses (250 mg/kg) showed splenic lymphoid depletion with occasional
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lymphoid necrosis and increased thymus weight. The immunological significance
of these effects are not known.
2.2.2.4 Neurological Effects
No studies were located regarding neurological effects in humans after
oral exposure to 1,2,3-trichloropropane.
There were no treatment-related changes in brain weight or brain
histology in rats and mice that were administered 1,2,3-trichloropropane doses
as high as 250 mg/kg/day for periods as long as 17 weeks (NTP 1983a, 1983b).
These data do not necessarily mean that 1,2,3-trichloropropane is not
neurotoxic, however, due to a lack of neurological evaluations.
2.2.2.5 Developmental Effects
No studies were located regarding developmental effects in humans or
animals after oral exposure to 1,2,3-trichloropropane.
2.2.2.6 Reproductive Effects
No studies were located regarding reproductive effects in humans after
oral exposure to 1,2,3-trichloropropane.
No effects on mating, fertility, or histological appearance of the
testes were found in male rats that were treated with 80 mg/kg/day
1,2,3-trichloropropane for 5 days in a dominant lethal mutation study (Saito-
Suzuki et al. 1982). Testis and epididymis weights were decreased in rats and
mice that were administered 1,2,3-trichloropropane doses as high as 125 mg/kg
for 60-120 days, but testicular histology, sperm counts, and sperm morphology
were normal or inconclusive (NTP 1983a, 1983b). Although a definite
conclusion regarding the reproductive toxicity of 1,2,3-trichloropropane in
this study is precluded by a lack of information on reproductive function and
the short exposure duration, the doses are considered NOAELs because the lack
of testicular histological lesions and effects on sperm reduces concern that
the decreased testicular and epididymal weights reflect a biologically
significant change. The NOAEL values for reproductive effects in both species
and duration categories are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.7 Genotoxic Effects
No studies were located regarding genotoxic effects in humans after oral
exposure to 1,2,3-trichloropropane.
As indicated in Section 2.2.2.6, orally administered
1,2,3-trichloropropane did not produce dominant lethal mutations in male rats
(Saito-Suzuki et al. 1982). Other mutagenicity studies are discussed in
Section 2.4.
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2.2.2.8 Cancer
No studies were located regarding carcinogenicity in humans after oral
exposure to 1,2,3-trichloropropane.
1,2,3-Trichloropropane has been demonstrated to be carcinogenic in a
variety of organs in Fischer-344 rats and B6C3Fl mice when administered by
gavage in corn oil in a 2-year study (NTP 1991). In male rats treated with
23 mg/kg/day, clear evidence of carcinogenicity was found, based on increased
incidences of squamous cell papilloma and carcinoma of the oral mucosa and/or
forestomach, pancreatic acinar adenoma, renal tubule adenoma, and preputial
gland adenoma and carcinoma. In female rats similarly treated, clear evidence
of carcinogenicity was also found, based on increased incidences of squamous
cell papilloma and carcinoma of the oral mucosa and forestomach, clitoral
gland adenoma and carcinoma, and mammary gland adenocarcinoma. High
incidences of Zymbal's gland carcinoma and intestinal adenocarcinoma were also
found in the male and female rats, and may be related to the
1,2,3-trichloropropane exposure.
Clear evidence of carcinogenicity was also found in male and female mice
treated with 6 mg/kg/day or greater (NTP 1991). The evidence consisted of
increased incidences of squamous cell carcinoma of the oral mucosa (females),
squamous cell papilloma and carcinoma of the forestomach (males and females),
hepatocellular adenoma or carcinoma (males and females), Harderian gland
adenoma (male and female), and uterine adenoma, adenocarcinoma, and stromal
polyp (females). High dose male mice (60 mg/kg/day) also had squamous cell
papilloma of the oral mucosa, which occurred in low incidence, but was
probably related to 1,2,3-trichloropropane treatment.
The lowest doses associated with cancer in rats and mice are recorded in
Table 2-2 and plotted in Figure 2-2 as Cancer Effect Levels (CELs).
2.2.3 Dermal Exposure
2.2.3.1 Death
No studies were located regarding death in humans after dermal exposure
to 1,2,3-trichloropropane.
Single dermal doses as low as 250 mg/kg caused death in rabbits (Alpert
1982). A dermal LD50 of 836 mg/kg has been determined for rats using
1,2,3-trichloropropane of relatively low purity (92%) (Clark 1977). The
treated skin of the animals in these studies was covered with an impervious
barrier for 24 hours to prevent evaporation of the volatile compound. The
cause of death is unclear, but symptoms suggestive of CNS impairment (e.g.,
ataxia, tremors, coma) and internal hemorrhage have been observed. Lethal
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dermal doses of 1,2,3-trichloropropane in these species are recorded in
Table 2-3.
2.2.3.2 Systemic Effects
Systemic effects resulting from dermal exposure to 1,2,3-trichloropropane
are discussed below. The highest NOAEL values and all reliable LOAEL
values for these effects in each species and duration category are recorded in
Table 2-3.
No studies were located regarding cardiovascular, hematological, or
musculoskeletal effects in humans or animals after dermal exposure to
1,2,3-trichloropropane.
Respiratory Effects. No studies were located regarding respiratory
effects in humans after dermal exposure to 1,2,3-trichloropropane.
Lung hemorrhage and apparently related effects (e.g., discoloration of
the lungs and liquid in the thoracic cavity) have been observed in rabbits
exposed to lethal dermal doses of 1,2,3-trichloropropane (Alpert 1982; Union
Carbide 1958).
Gastrointestinal Effects. No studies were located regarding
gastrointestinal effects in humans after dermal exposure to
1,2,3-trichloropropane.
Ulceration of the stomach wall was observed in rabbits exposed to lethal
dermal doses of 1,2,3-trichloropropane (Alpert 1982).
Hepatic Effects. No studies were located regarding hepatic effects in
humans after dermal exposure to 1,2,3-trichloropropane.
Turgid and discolored livers were observed in rabbits exposed to lethal
dermal doses of 1,2,3-trichloropropane (Alpert 1982; Union Carbide 1958).
These macroscopic alterations are consistent with oral and inhalation evidence
of hepatotoxicity.
Renal Effects. No studies were located regarding renal effects in
humans after dermal exposure to 1,2,3-trichloropropane.
Discolored kidneys and hematuria were observed in rabbits exposed to
lethal dermal doses of 1,2,3-trichloropropane (Alpert 1982; Union Carbide
1958). These macroscopic alterations are consistent with oral and inhalation
evidence of renal toxicity.
Dermal/Ocular Effects. No studies were located regarding dermal effects
in humans after dermal exposure to 1,2,3-trichloropropane. Limited
information indicates that brief (15-minute) exposure to 100 ppm
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1,2,3-trichloropropane vapor causes eye irritation in humans (Silverman et al.
1946).
1,2,3-Trichloropropane vapor caused eye irritation in rats and mice
exposed for 4 hours to concentrations as low as 126 ppm (Gushow and Quast
1984) and in rats exposed intermittently to concentrations as low as 15 ppm
over a period of 13 weeks (Johannsen et al. 1988). Ocular application of
1,2,3-trichloropropane caused eye irritation in rabbits (Alpert 1982; Clark
1977).
Dermal application of 1,2,3-trichloropropane causes severe skin
irritation in rabbits. Evidence suggests that prolonged exposure (e.g., for
24 hours) or repeated daily application (e.g., for 2 weeks) may be necessary
to cause irritation (Clark 1977; McOmie and Barnes 1949). The results of one
study suggest that 1,2,3-trichloropropane in corn oil vehicle was a very mild
skin sensitizer in guinea pigs (Clark 1977). Another study that used a less
sensitive procedure found no evidence of skin sensitization by undiluted
1,2,3-trichloropropane in guinea pigs (Alpert 1982). This study also found
that corn oil itself was a mild skin sensitizer in guinea pigs, indicating
that there is a possibility that the vehicle may enhance the weak effect
observed by Clark (1977).
2.2.3.3 Immunological Effects
No studies were located regarding immunological effects in humans after
dermal exposure to 1,2,3-trichloropropane.
As indicated in the discussion of Dermal/Ocular Effects in
Section 2.2.3.2, one study provides limited evidence that
1,2,3-trichloropropane may be a very weak dermal sensitizer in animals (Clark
1977).
No studies were located regarding the following effects in humans or
animals after dermal exposure to 1,2,3-trichloropropane:
2.2.3.4 Neurological Effects
2.2.3.5 Developmental Effects
2.2.3.6 Reproductive Effects
2.2.3.7 Genotoxic Effects
Other mutagenicity studies are discussed in Section 2.4.
2.2.3.8 Cancer
No studies were located regarding carcinogenicity in humans or animals
after inhalation exposure to 1,2,3-trichloropropane.
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2.3 TOXICOKINETICS
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
No quantitative information was located regarding absorption of
1,2,3-trichloropropane in humans or animals following inhalation exposure;
however, since liver and kidney toxicity has been reported in animals exposed
by the inhalation route (see discussions of Hepatic Effects and Renal Effects
in Section 2.2.1.2), it can be concluded that absorption occurs to some
extent.
2.3.1.2 Oral Exposure
No quantitative information was located regarding absorption of
1,2,3-trichloropropane in humans following oral exposure.
The results of studies performed in rats indicate that near complete
absorption (greater than 80%) from the gastrointestinal tract occurs within
the first day following oral exposure (Sipes et al. 1982; Volp et al. 1984).
2.3.1.3 Dermal Exposure
No quantitative information was located regarding absorption of
1,2,3-trichloropropane in humans or animals following dermal exposure.
However, internal pathology and death have been reported in animals exposed by
the-dermal route (see Sections 2.2.3.1 and 2.2.3.2). Since vapor exposure was
unlikely due to occlusive covering of the treatment area, it can be concluded
that dermal absorption occurs to some extent.
2.3.2 Distribution
2.3.2.1 Inhalation Exposure
No information was located regarding the distribution of
1,2,3-trichloropropane in humans or animals following inhalation exposure.
2.3.2.2 Oral Exposure
No information was located regarding the distribution of
1,2,3-trichloropropane in humans following oral exposure.
Muscle, blood, liver, skin, and adipose tissue contained the largest
amounts of 1,2,3-trichloropropane following oral exposure in rats (Sipes et
al. 1982). Retention in all tissues was low, however, as elimination of
1,2,3-trichloropropane-derived radioactivity from tissues was nearly complete
(greater than 97%) within 8 days after exposure.
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Elimination of 1,2,3-trichloropropane from tissues is nearly complete
(greater than 97%) within 8 days after oral exposure in rats (Sipes et al.
1982).
2.3.2.3 Dermal Exposure
No information was located regarding the distribution of
1,2,3-trichloropropane in humans or animals following dermal exposure.
2.3.2.4. Other Routes of Exposure
No information was located regarding the distribution of
1,2,3-trichloropropane in humans following exposure by other routes.
Distribution studies of intravenously injected 1,2,3-trichloropropane in
rats have provided a quantitative description of the distribution kinetics
from which predictions can be made regarding other routes of exposure (Sipes
et al. 1982; Volp et al. 1984). Intravenously injected 1,2,3-trichloropropane
rapidly distributes to many tissues. The major sites of accumulation are
liver, kidney, small and large intestine, adipose tissue, muscle, and skin.
Peak concentrations are achieved within l-2 hours after intravenous injection.
Elimination of 1,2,3-trichloropropane from tissues in the rat is also
rapid and a two-phase process (Volp et al. 1984). Elimination half-times for
greater than 90% of the 1,2,3-trichloropropane in tissues ranged from
20 minutes in kidney to 2 hours in adipose tissue (first phase). A small
fraction of the 1,2,3-trichloropropane in these tissues (less than 10%) was
eliminated more slowly, with half-times ranging from 23 to 45 hours (second
phase). Elimination of total radioactivity from the tissues after intravenous
injection of radiolabeled 1,2,3-trichloropropane (phase one half-times between
2-5 hours, phase two half-time between 87-182 hours) is slower than
elimination of parent 1,2,3-trichloropropane. This suggests that metabolites
of 1,2,3-trichloropropane are eliminated slower than the parent compound.
Based on the results of studies in the rat, it can be concluded that
1,2,3-trichloropropane absorbed by any route is likely to be widely
distributed in the body. Most of the 1,2,3-trichloropropane that enters
tissues is eliminated within hours to days.
2.3.3 Metabolism
No information was located regarding the metabolism of
1,2,3-trichloropropane in humans; however, studies in animals have provided
information about metabolic pathways and rates of metabolism that are likely
to occur in humans. Intravenously injected 1,2,3-trichloropropane is
extensively metabolized within hours in rats. Metabolic products in rats
include carbon dioxide, which is expired, and numerous unidentified
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metabolites that are excreted in urine and enter the bile to be excreted in
feces or absorbed in the intestines (Sipes et al. 1982; Volp et al. 1984).
Although the nonvolatile metabolites of 1,2,3-trichloropropane that are formed
in the rat have not been identified, dehalogenation products, glutathione
conjugates, and subsequent metabolites (e.g., mercapturic acids) can be
anticipated, based on the metabolic pathways that have been identified for
other halogenated alkanes.
Chloroalkanes such as 1,2,3-trichloropropane undergo dehalogenation
reactions catalyzed by cytochrome P-450 (Ivanetich et al. 1978; Salmon et al.
1981; Van Dyke et al. 1971). Depending on the reaction mechanism, highly
reactive intermediates (e.g., radicals) can be formed from these reactions
leading to protein and DNA adducts or lipid peroxidation. Conjugation with
glutathione could result in formation of sulfur mustard-like compounds that
are potential alkylating agents.
2.3.4 Excretion
2.3.4.1 Inhalation Exposure
No information was located regarding the excretion of
1,2,3-trichloropropane in humans or animals following inhalation exposure.
2.3.4.2 Oral Exposure
No information was located regarding the excretion of
1,2,3-trichloropropane in humans following oral exposure.
Studies conducted with rats showed that 1,2,3-trichloropropane and its
metabolites were excreted in urine, feces, and exhaled breath after oral
exposure (Sipes et al. 1982). Excretion was nearly complete (95-96%) within
2 days. Most of the dose was excreted in the urine and feces (up to 56% and
25%, respectively), with the remainder in the breath.
2.3.4.3 Dermal Exposure
No information was located regarding the excretion of
1,2,3-trichloropropane in humans or animals following dermal exposure.
2.3.4.4 Other Routes of Exposure
No information was located regarding the excretion of
1,2,3-trichloropropane in humans following other routes of exposure.
Studies of the excretion of intravenously injected 1,2,3-trichloropropane
in rats have provided a quantitative description of the excretion
kinetics from which predictions can be made about other routes of exposure
(Sipes et al. 1982; Volp et al. 1984). Excretion of intravenously injected
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1,2,3-trichloropropane and metabolites is nearly complete within 2 days.
Unchanged 1,2,3-trichloropropane and its major metabolite, carbon dioxide, are
expired in exhaled breath. Nonvolatile metabolites are excreted in the urine.
Extensive biliary excretion of nonvolatile metabolites also occurs, resulting
in fecal excretion as well as reabsorption of metabolites from the
gastrointestinal tract. Based on the results of studies in rats, exhaled
breath, urine, and feces are likely to be significant routes of excretion of
absorbed 1,2,3-trichloropropane and its metabolites in humans.
2.4 RELEVANCE TO PUBLIC HEALTH
The only information that is available on the health effects of
1,2,3-trichloropropane in humans indicates that exposure to
1,2,3-trichloropropane of unknown purity in air can produce eye and throat
irritation. Effects in the respiratory system, eyes and skin,
gastrointestinal tract, liver, kidneys, blood, and spleen have been observed
in animals exposed to 1,2,3-trichloropropane by air, mouth, and/or skin.
1,2,3-Trichloropropane also induced tumors at multiple sites in animals
exposed orally.
Sufficient information is available on the health effects of
1,2,3-trichloropropane to derive MRLs for acute duration inhalation exposure
and intermediate duration oral exposure. Based on a NOAEL of 1 ppm for
histological changes in the nasal olfactory epithelium of rats (Miller et al.
1986b), an acute inhalation MEL of 0.0003 ppm was calculated by adjusting the
NOAEL for intermittent exposure, converting the adjusted NOAEL to an
equivalent concentration in humans, and dividing the equivalent concentration
by an uncertainty factor of 100 (10 for extrapolation from animals to humans,
and 10 for human variability). The LOAEL for effects on the olfactory
epithelium (decreased thickness) in rats is 3 ppm (Miller et al. 1986b).
Supporting studies show that similar nasal effects occurred in mice at 10 ppm,
and more pronounced changes in nasal tissues occurred in rats and mice at
higher concentrations (Miller et al. 1986a, 1986b). An intermediate duration
inhalation MEL for 1,2,3-trichloropropane cannot be derived due to a lack of
information on effects on the nasal olfactory epithelium which, based on the
acute data, is the critical target of inhalation exposure. A chronic
inhalation MEL is precluded by a lack of data on chronic toxicity.
Insufficient information is available on the systemic effects of acute oral
exposure to 1,2,3-trichloropropane at sublethal doses to derive an acute oral
MEL. Based on a NOAEL of 8 mg/kg/day for hepatic effects in rats (NTP 1983a),
an oral MEL of 0.06 mg/kg/day was calculated for intermediate duration
exposure by dividing the NOAEL by an uncertainty factor of 100 (10 for
extrapolation from animals to humans, and 10 for human variability). The
LOAEL for hepatic effects (increased liver weight, decreased serum
cholinesterase) is 16 mg/kg/day (NTP 1983a). The NOAEL and LOAEL for anemia
in rats are the same as the NOAEL and LOAEL for hepatic effects, but other
data that lend support to the intermediate oral MEL are not available. A
chronic oral MEL is precluded by lack of information on chronic toxicity.
36
2. HEALTH EFFECTS
Acute-duration, intermediate-duration, and chronic duration dermal MRLs were
not derived for 1,2,3-trichloropropane due to the lack of an appropriate
methodology for the development of dermal MRLs.
Death. Information regarding death in humans following exposure to
1,2,3-trichloropropane by any route was not found.
Studies with rats and mice suggest that 1,2,3-trichloropropane is
similarly toxic following acute- and intermediate-duration exposure by either
the inhalation or oral route. Lethal concentrations as low as approximately
300 ppm for inhalation exposure and lethal doses in the range of 125-250 mg/kg
for gavage exposure indicate that the 1,2,3-trichloropropane is likely to be
moderately toxic for humans. However, 1,2,3-trichloropropane may be less
toxic when ingested gradually throughout the day, such as in the drinking
water, than when taken as a bolus. Acute dermal and oral lethal doses of
1,2,3-trichloropropane in animals appear to be similar in magnitude,
suggesting that skin contact with liquid 1,2,3-trichloropropane at waste sites
could be toxic for humans. The dermal doses may actually overestimate
lethality, however, because the testing methods may have prevented evaporation
of 1,2,3-trichloropropane from the skin.
Systemic Effects.
Respiratory Effects. The respiratory tract is a principal target of
inhaled 1,2,3-trichloropropane in studies with humans and animals. Human
subjects experienced objectionable throat and eye irritation at 100 ppm. Some
subjects found 50 ppm unacceptable for an 8-hour day, but information on
irritation in humans at lower concentrations is not available. Rodent data
showing that 1,2,3-trichloropropane causes irritative effects in the
respiratory tract, eyes, and skin following vapor exposure, and in the
gastrointestinal tract following oral exposure support the fact that
1,2,3-trichloropropane is a local irritant in humans. Effects indicative of
local irritation have occurred in rats and mice at air concentrations as low
as 3 ppm (rats); these effects consisted of microscopic alterations in the
nasal cavity (inflammatory and degenerative changes) and bronchi (lymphoid
hyperplasia). The animal evidence suggests that the nasal olfactory
epithelium is more sensitive than the respiratory epithelium to inhaled
1,2,3-trichloropropane, but most inhalation studies, including the only
intermediate-duration study in animals (rats), did not examine the nasal
cavity. Because rodents are obligate nose breathers (Miller et al. 1986a,
1986b), histologicai alterations in rodent olfactory mucosa might be
pronounced in comparison to humans, who are capable of breathing via the
mouth. However, because the effects on the olfactory tissue are progressive
and show the potential for olfactory impairment in humans, they are an
appropriate basis for the acute inhalation MRL.
Histological effects have also been observed in the nasal cavity and
bronchiolar epithelium of rats and/or mice that were exposed to
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1,2,3-trichloropropane for acute and intermediate durations by oral intubation
at doses of 63 mg/kg/day and more. These effects seem to be generally
consistent with those found in the inhalation studies and confirm that
1,2,3-trichloropropane is a probable respiratory tract toxicant in humans.
The nasal effects ranged from inflammation to mucosal necrosis at lethal
doses, but appear to have occurred principally in the dorsal posterior nasal
mucosa rather than the olfactory mucosa. The pathogenesis of the nasal
lesions in orally treated animals is unclear since the principal location of
the nasal effects in these animals (dorsal posterior) may suggest a local
rather than systemic effect. This could possibly result from small amounts of
residual compound in the pharynx after dosing, escape of volatile material
from the stomach into the nasal passages, or elimination of
1,2,3-trichloropropane or metabolites in expired air. Therefore, the
respiratory effects seen in animals after gavage exposure may be relevant to
human exposure to 1,2,3-trichloropropane via drinking water because
1,2,3-trichloropropane could also escape from the pharynx and stomach into the
nasal passages or be eliminated in expired air after exposure by this route.
The relevance of the effects in the bronchiolar epithelium, which were
primarily regenerative changes such as hyperplasia in mice, is uncertain
because it is possible that they were caused by exposure due to improper
gavage treatment. This possibility may be substantive since there were a
number of deaths resulting from faulty intubation techniques in the same
study. Based on the overall evidence from animal studies, it appears that
continued exposure to 1,2,3-trichloropropane in air or water at sufficiently
high levels may be capable of producing adverse changes in nasal tissues of
humans.
Hematological Effects. 1,2,3-Trichloropropane has not been reported to
produce hematological effects in humans. Nonregenerative anemia occurred in
rats orally exposed to 1,2,3-trichloropropane for intermediate durations.
This is one of most sensitive effects of 1,2,3-trichloropropane in animals.
Effects in the spleen (increased hematopoiesis, decreased spleen weight or
lymphoid depletion) in rats and mice exposed orally or by inhalation may
indicate hematological effects of 1,2,3-trichloropropane, but the biological
significance of these changes is uncertain because anemia was the only
abnormal hematology measurement in the rats and hematology was normal in the
mice. Overall, the animal data suggest some potential for adverse
hematological effects in humans exposed to 1,2,3-trichloropropane.
Hepatic Effects. Adverse effects on the liver in humans have not been
reported; however, the liver is a major target organ of 1,2,3-trichloropropane
in animals. 1,2,3-Trichloropropane causes dose-related hepatic toxicity that
is severe enough at high doses to contribute to death in rats and mice
following acute- or intermediate-duration gavage administration.
1,2,3-Trichloropropane appears to be less hepatotoxic when ingested throughout
the day (i.e., in drinking water) than when taken as a bolus. Hepatic effects
other than increased liver weight and hepatocellular hypertrophy have not been
observed in rats and mice exposed by inhalation, but examinations were not
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performed on animals exposed for periods longer than 13 weeks. Gavage studies
show that the changes in the liver are progressive, with increased organ
weights, minimal histological alterations, and/or clinical chemistry
alterations occurring at lower doses. The most sensitive hepatic effect
observed appears to be decreased serum pseudocholinesterase activity which, in
the absence of known inhibitors, suggests depressed synthesis due to
hepatocellular damage (NTP 1983a). The oral MRL for intermediate-duration
exposure is based on this effect. There was macroscopic evidence of liver
damage in rabbits that died following acute dermal exposure to
1,2,3-trichloropropane. Although effects on the liver have not been observed
in humans, the studies in animals indicate that such hepatic effects might
occur in humans at sufficiently high or prolonged exposures.
Renal Effects. Adverse effects on the kidneys in humans have not been
reported, but the kidneys are a major target of 1,2,3-trichloropropane
toxicity in animals. 1,2,3-Trichloropropane causes dose-related renal
toxicity that is severe enough at high doses to contribute to death in rats
and mice following acute- or intermediate-duration gavage administration.
1,2,3-Trichloropropane appears to be less toxic to the kidneys when ingested
throughout the day (i.e., in drinking water) than when taken as a bolus.
Renal effects other than increased kidney weights have not been observed in
rats exposed by inhalation, but examinations were not performed on animals
exposed for longer than 13 weeks. Gavage studies indicate that the renal
effects are progressive, with increased organ weight and clinical chemistry
alterations occurring at lower doses. Macroscopic evidence of kidney damage
was observed in rabbits that died following acute dermal exposure to
1,2,3-trichloropropane. Although effects on kidneys have not been observed in
humans, the studies in animals indicate that renal effects might occur in
humans at sufficiently high or prolonged exposures.
Other Systemic Effects. Other systemic effects observed in rats
following intermediate-duration oral exposure to 1,2,3-trichloropropane
included weight loss, alopecia, and histological changes in the thyroid
(reduced follicular size, increased epithelial height). Insufficient
information is available to determine if 1,2,3-trichloropropane is likely to
produce these effects in exposed humans.
Immunological Effects. Immunological effects of 1,2,3-trichloropropane
have not been reported in humans. Intermediate-duration studies with rats and
mice have shown effects in the spleen and thymus (lymphoid depletion and/or
decreased organ weight) following oral or inhalation exposure. The effects
occurred at high levels of exposure, frequently in the lethal range. These
effects cannot be used to infer immunotoxicity of 1,2,3-trichloropropane in
humans because immune function has not been evaluated.
Neurological Effects. Neurological effects of 1,2,3-trichloropropane
have not been reported in humans. Signs suggestive of CNS impairment occur in
rodents exposed to lethal levels of 1,2,3-trichloropropane by the inhalation,
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oral, and dermal routes, but these effects do not necessarily indicate that
1,2,3-trichloropropane is neurotoxic because they could be due to indirect
causes (e.g., asphyxiation, kidney failure) in dying animals. Brain weights
were reported to have increased in rats that inhaled lethal concentrations of
1,2,3-trichloropropane in an intermediate-duration study, but this could
simply reflect a decrease in body weight (i.e., if relative brain weight was
increased). Since the studies that reported the aforementioned effects did
not perform neurological or behavioral evaluations, insufficient information
is available to determine if 1,2,3-trichloropropane is likely to produce
neurological effects in humans at sublethal levels.
Developmental Effects. Developmental effects of 1,2,3-trichloropropane
have not been reported in humans. 1,2,3-Trichloropropane did not produce
effects on survival or growth during gestation or lactation in offspring of
rats exposed by inhalation, but teratogenicity was not evaluated.
Developmental toxicity of 1,2,3-trichloropropane has not been evaluated in
animals exposed orally or dermally. There was no evidence of teratogenicity
or fetal toxicity in rats treated with a maximum tolerated dose of
1,2,3-trichloropropane (37 mg/kg) by intraperitoneal injection on days l-15 of
gestation (Hardin et al. 1981). Although the available data provide some
assurance that 1,2,3-trichloropropane is not developmentally toxic in animals,
additional information, particularly teratogenicity evaluations in animals by
environmentally relevant routes of exposure, would be needed to prove that
1,2,3-trichloropropane is not a likely developmental toxicant in humans.
Reproductive Effects. Reproductive effects of 1,2,3-trichloropropane in
humans have not been reported. There were no effects on mating performance or
fertility in rats exposed orally for 5 days or by inhalation at relatively low
concentrations (less than or equal to 15 ppm) for 10 weeks. Oral
administration for up to 4 months at lethal levels caused decreased testes and
epididymis weights in rats and mice, but no effects on testicular histology or
sperm. Rats exposed by inhalation for 4 weeks at lethal levels experienced
decreased testes and ovary weights, but histology and sperm were not
evaluated. Although effects of 1,2,3-trichloropropane on reproductive
function have not been evaluated in animals treated at high (near maximum
tolerated) doses or concentrations, the normal testicular histology and sperm
counts and morphology at lethal levels in the 4-week inhalation study are
consistent with normal reproductive function. Overall, the available data
suggest that 1,2,3-trichloropropane will not be a reproductive toxicant in
humans.
Genotoxic Effects. Genotoxic effects of 1,2,3-trichloropropane in
humans have not been reported. 1,2,3-trichloropropane was mutagenic in
certain strains of Salmonella typhimurium when assayed with exogenous
metabolic activation preparation, and it induced sister chromatid exchanges in
cultured hamster cells (Table 2-4). 1,2,3-trichloropropane did not induce
dominant lethal mutations when administered orally to rats (Saito-Suzuki et
al. 1982) (see Section 2.2.2.7). Although only limited data are available,
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this evidence indicates that 1,2,3-trichloropropane is genotoxic in animals
and may be genotoxic in humans.
Cancer. Information regarding the carcinogenicity of 1,2,3-trichloropropane
in humans by any route of exposure was not located. Clear evidence of
carcinogenicity was found for 1,2,3-trichloropropane in male and female rats
at doses of 3 mg/kg/day or more and in male and female mice at doses of
6 mg/kg/day or more in a 2-year gavage study (NTP 1991). Increased incidences
of squamous cell papilloma and/or carcinoma were found in the oral mucosa
and/or the forestomach of both sexes of both species. These tumors were
morphologically similar in the oral mucosa and forestomach, forming a
continuum. Other tumors that were considered to be related to
1,2,3-trichloropropane exposure consisted of pancreatic acinar adenoma, renal
tubule adenoma, adenoma and carcinoma of the preputial gland in male rats;
clitoral gland adenoma and carcinoma, mammary gland adenocarcinoma in female
rats; hepatocellular adenoma and carcinoma and Harderian gland adenoma in male
and female mice; and uterine neoplasms in female mice. Zymbal's gland
carcinoma and intestinal adenocarcinoma also found in the male and female rats
may be related to the 1,2,3-trichloropropane exposure. The carcinogenicity of
1,2,3-trichloropropane is consistent with the positive genotoxicity findings
in the presence of bioactivation (see Table 2-4) and with its metabolism to
reactive intermediates, such as alkylating agents, which can lead to protein
and DNA adducts (see Section 2.3.3). NTP, IARC, and EPA have not yet
classified 1,2,3-trichloropropane with respect to its potential
carcinogenicity for humans, but the evidence in both sexes of two species of
animals strongly suggests a public health concern.
2.5 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in
biologic systems or samples. They have been classified as markers of
exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989).
A biomarker of exposure is a xenobiotic substance or its metabolite(s)
or the product of an interaction between a xenobiotic agent and some target
molecule(s) or cell(s) that is measured within a compartment of an organism
(NAS/NRC 1989). The preferred biomarkers of exposure are generally the
substance itself or substance-specific metabolites in readily obtainable body
fluid(s) or excreta. However, several factors can confound the use and
interpretation of biomarkers of exposure. The body burden of a substance may
be the result of exposures from more than one source. The substance being
measured may be a metabolite of another xenobiotic substance (e.g., high
urinary levels of phenol can result from exposure to several different
aromatic compounds). Depending on the properties of the substance (e.g.,
biologic half-life) and environmental conditions (e.g., duration and route of
exposure), the substance and all of its metabolites may have left the body by
the time biologic samples can be taken. It may be difficult to identify
individuals exposed to hazardous substances that are commonly found in body
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tissues and fluids (e.g., essential mineral nutrients such as copper, zinc,
and selenium). Biomarkers of exposure to 1,2,3-trichloropropane are discussed
in Section 2.5.1.
Biomarkers of effect are defined as any measurable biochemical,
physiologic, or other alteration within an organism that, depending on
magnitude, can be recognized as an established or potential health impairment
or disease (NAS/NRC 1989). This definition encompasses biochemical or
cellular signals of tissue dysfunction (e.g., increased liver enzyme activity
or pathologic changes in female genital epithelial cells), as well physiologic
signs of dysfunction such as increased blood pressure or decreased lung
capacity. Note that these markers are often not substance specific. They
also may not be directly adverse, but can indicate potential health impairment
(e.g., DNA adducts). Biomarkers of effects caused by 1,2,3-trichloropropane
are discussed in Section 2.5.2.
A biomarker of susceptibility is an indicator of an inherent or acquired
limitation of an organism's ability to respond to the challenge of exposure to
a specific xenobiotic substance. It can be an intrinsic genetic or other
characteristic or a preexisting disease that results in an increase in
absorbed dose, biologically effective dose, or target tissue response. If
biomarkers of susceptibility exist, they are discussed in Section 2.7,
"POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE."
2.5.1 Biomarkers Used,to Identify and/or Quantify Exposure
      to 1,2,3-Trichloropropane
Biomarkers of exposure to 1,2,3-trichloropropane cannot be identified
because information on levels of 1,2,3-trichloropropane or its metabolites in
human tissues, fluids, or excreta or information on effects specific for
1,2,3-trichloropropane is not available. Studies with rats indicate that
excretion of 1,2,3-trichloropropane in the breath or urine may be sufficient
for monitoring purposes (see Section 2.3.4). Mild anemia and serum enzyme
alterations associated with liver toxicity, particularly decreased serum
pseudocholinesterase activity, occurred in rats exposed to
1,2,3-trichloropropane. The enzyme alterations were used as the basis for the
intermediate-duration oral MRL. Although the anemia and enzyme alterations
are sensitive indicators of toxicity in rats, they are not specific indicators
of exposure to 1,2,3-trichloropropane and may not occur in humans.
2.5.2 Biomarkers Used to Characterize Effects Caused by
      1,2,3-Trichloropropane
Effects in humans that are specifically attributable to 1,2,3-
trichloropropane
exposure are not known. Principal targets of 1,2,3-trichloropropane
in animals are the respiratory tract, blood, liver, and kidneys (see
Section 2.4). One study with rats suggests that alterations of serum enzymes
(e.g., decreased serum pseudocholinesterase activity) and anemia might be
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useful biomarkers for hepatic and hematologic effects, respectively, of
1,2,3-trichloropropane. Insufficient data exist, however, to determine
whether 1,2,3-trichloropropane is likely to cause anemia in humans, and
substances other than 1,2,3-trichloropropane could also cause similar
hematologic and hepatic effects.
2.6 INTERACTIONS WITH OTHER CHEMICALS
Rats were exposed by inhalation to 500 ppm 1,2,3-trichloropropane and
1,000 ppm dichloropropane alone and in combination for 4 hours (Drew et al.
1978). Activities of liver-associated serum enzymes (serum glutamicoxaloacetic
transaminase, serum glutamic-pyruvic transaminase, ornithine
carbamyl transferase) were increased 24-48 hours following exposure to each
chemical alone. The combined exposure resulted in higher enzyme activities
than with either chemical alone, but the increases were less than additive.
2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
No populations with unusual susceptibility to health effects of
1,2,3-trichloropropane have been identified. The respiratory tract, blood,
liver, and kidneys are principal targets of 1,2,3-trichloropropane in animals
(see Section 2.4). It is therefore possible that people with chronic
respiratory, liver, or kidney disease, or possibly people with compromised
pulmonary, hepatic, or renal function (e.g., alcoholics), might be unusually
susceptible to 1,2,3-trichloropropane.
2.8 MITIGATION OF TOXICOLOGICAL EFFECTS
This section will describe the clinical practice and research methods
for reducing toxic effects of exposure to 1,2,3-trichloropropane. However,
because some the treatments discussed may be experimental and unproven, this
section should not be used as a guide for treatment of exposures to
1,2,3-trichloropropane. When specific exposures have occurred poison control
centers and medical toxicologists should be consulted for medical advice.
Human exposure to 1,2,3-trichloropropane may occur by inhalation,
ingestion, or by dermal contact. Specific information on the management and
treatment of toxicological effects following acute exposure to
1,2,3-trichloropropane were not located in the literature. However, since
effects of 1,2,3-trichloropropane are consistent with those produced by other
halogenated aliphatic hydrocarbons compounds, general information on
mitigation for this chemical class pertains to 1,2,3-trichloropropane (Stutz
and Janusz 1988). Mitigation approaches to reduce absorption of
1,2,3-trichloropropane have included general recommendations of separating
contaminated food, water, air, and clothing from the exposed individual.
Externally, 1,2,3-trichloropropane can produce irritation and injury to the
skin and mucous membranes. Exposed eyes are flushed with a clean neutral
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solution such as water or normal saline. The skin is immediately washed with
large amounts of soapy water.
If oral exposure has occurred, inducing emesis may be indicated within
the first 30 minutes following substantial ingestion unless the patient is or
could rapidly become obtunded, comatose, or convulsing (HSDB 1992). The
victim is then given water or milk to dilute the chemical and activated
charcoal to adsorb the chemical (Stutz and Janusz 1988). Although of unproven
value in all cases of ingestion, administration of a cathartic such as
magnesium sulfate may stimulate fecal excretion of the chemical before it is
completely absorbed by the body (Stutz and Janusz 1988).
Little information specific to enhancing excretion or reducing body
burden of 1,2,3-trichloropropane was available. However, animal data indicate
that once absorbed orally in rats, 95-96% of 1,2,3-trichloropropane is
excreted within 2 days. Most of the dose (56%) was excreted in the urine and
25% in the feces, with the remainder exhaled in the breath. (Sipes et al.
1982). Mitigation strategies to increase urinary output and dilute the
chemical in humans might include flushing the gastrointestinal and circulatory
systems with fluid while carefully monitoring fluid and electrolyte balances.
Muscle, blood, liver, skin, and adipose tissue contained the largest amounts
of radiolabled 1,2,3-trichloropropane following oral exposure in rats (Sipes
et al. 1982).
Based on metabolic pathways for other chloroalkanes, 1,2,3-trichloropropane
probably undergoes dehalogenation reactions via cytochrome P-450
dependent microsomal metabolism, resulting in the formation of highly reactive
intermediates that may lead to protein and DNA adducts or lipid peroxidation
(Ivanetich et al. 1978; Salmon et al. 1981; Van Dyke et al. 1971). If the
mechanism of 1,2,3-trichloropropane induced toxicity involves the action of
reactive intermediates, administration of chemicals that interfere with these
metabolic processes might be effective in reducing adverse health effects.
2.9 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA as amended directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of 1,2,3-trichloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the National
Toxicology Program (NTP), is required to assure the initiation of a program of
research designed to determine the health effects (and techniques for
developing methods to determine such health effects) of
1,2,3-trichloropropane.
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
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the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
2.9.1 Existing Information on Health Effects of 1,2,3-Trichloropropane
The existing data on health effects of inhalation, oral, and dermal
exposure of humans and animals to 1,2,3-trichloropropane are summarized in
Figure 2-3. The purpose of this figure is to illustrate the existing
information concerning the health effects of 1,2,3-trichloropropane. Each dot
in the figure indicates that one or more studies provide information
associated with that particular effect. The dot does not imply anything about
the quality of the study or studies. Gaps in this figure should not be
interpreted as "data needs" information (i.e., data gaps that must necessarily
be filled).
Information on health effects of 1,2,3-trichloropropane in humans is
limited to one report of systemic effects (eye and throat irritation)
resulting from acute vapor exposure (Silverman et al. 1946). As indicated in
Figure 2-3, data are available for the lethality, acute systemic toxicity,
intermediate systemic toxicity, and reproductive effects of 1,2,3-trichloropropane
in animals exposed by the oral and inhalation routes. Limited
information is available for immunologic and neurologic effects by the
inhalation and oral routes, and developmental and genotoxic effects by the
oral route. Information is also available on the carcinogenicity of
1,2,3-trichloropropane in animals exposed by the oral route. Dermal toxicity
studies of 1,2,3-trichloropropane provide acute lethality data and limited
information on acute systemic and neurologic effects.
2.9.2 Data Needs
Acute-Duration Exposure. There is evidence that 1,2,3-trichloropropane
vapor irritates the eyes and throat of humans (Silverman et al. 1946), but
information on other targets of acute 1,2,3-trichloropropane toxicity in
humans is not available. The respiratory tract, liver, and kidneys appear to
be principal targets of 1,2,3-trichloropropane toxicity in rats and mice
following inhalation or oral exposure for approximately 2 weeks (Miller et al.
1986a, 1986b; NTP 1983a, 1983b), and are likely targets of acute exposure in
humans. Sufficient respiratory (nasal) effects data are available on which to
base an acute MRL for inhalation exposure (Miller et al. 1986b). Respiratory
effects of 1,2,3-trichloropropane, however, have been investigated in only two
animal species (rats and mice). Studies with other species could confirm that
the respiratory system is the most sensitive target of acute-duration
inhalation exposure to 1,2,3-trichloropropane. Additional acute oral studies
could help characterize the systemic effects of 1,2,3-trichloropropane at
sublethal doses to enable determination of an acute-duration oral MRL.
Information is available for effects of 1,2,3-trichloropropane on the skin and

47
2. HEALTH EFFECTS
eyes (Alpert 1982; Clark 1977; Gushow and Quast 1984), but not on other
tissues, following acute nonlethal dermal exposure. There are no
pharmacokinetic data available to support the identification of target organs
across routes of exposure. Dermal studies may not be necessary to provide
information on systemic toxicity since it appears, based on inhalation and
oral data, that systemic effects of 1,2,3-trichloropropane, other than
respiratory effects, may not be route-specific.
Intermediate-Duration Exposure. Information is not available on
systemic effects of 1,2,3-trichloropropane in humans following intermediate-
duration exposure by any route. The respiratory system, blood, liver, and
kidneys appear to be principal targets of 1,2,3-trichloropropane in rats and
mice exposed by inhalation or orally for intermediate durations (Johannsen et
al. 1988; NTP 1983a, 1983b; Villeneuve et al. 1985), but studies longer than
2-4 months have not been performed (inhalation) or are not completed (NTP oral
bioassay; see Section 2.8.3). The spleen and thyroid are less sensitive
targets of intermediate-duration oral exposure in animals (NTP 1983a;
Villeneuve et al. 1985), but the biological significance of effects observed
in these organs is uncertain. Although intermediate-duration inhalation
studies with animals are consistent with acute data in showing the respiratory
system to be a target of 1,2,3-trichloropropane toxicity, intermediate-
duration exposure levels that do not cause adverse respiratory (nasal) effects
have not been determined. Although the respiratory system does not appear to
be the most sensitive target for intermediate-duration oral exposure, drinking
water studies could help ascertain if the pulmonary effects observed in gavage
studies are a consequence of the method of treatment. Sufficient information
is available from one study (NTP 1983a) to determine a dose that does not
cause adverse hepatic and hematologic effects and to derive an MRL for
intermediate-duration oral exposure based on these effects. Confidence in
this MRL could be strengthened by additional studies. Additional information
would be useful to determine if intermediate-duration exposure to
1,2,3-trichloropropane is capable of causing biologically significant
alterations to the spleen and thyroid, particularly at doses in the range for
nonadverse liver and hematologic effects. Information is not available on
effects of intermediate-duration dermal exposure to 1,2,3-trichloropropane in
animals, and there are no pharmacokinetic data to support the identification
of target organs across routes of exposure. Acute-duration toxicity data,
however, suggest that systemic effects of 1,2,3-trichloropropane, other than
respiratory effects, may not be route-specific.
Chronic-Duration Exposure and Cancer. Information is not available
regarding the chronic toxicity of 1,2,3-trichloropropane in humans or animals
exposed by any route. Chronic studies in animals could provide information on
progression or reversibility of effects caused by subchronic exposure,
particularly respiratory system effects following inhalation exposure and
liver and hematological effects following oral exposure. Chronic studies in
animals also could enable identification of effects produced by low-level
exposure that might not be detected in shorter-duration studies.
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The carcinogenicity of 1,2,3-trichloropropane in humans or animals
exposed by any route has not been evaluated. 1,2,3-trichloropropane induced
multiple site tumors in both sexes of rats and mice exposed orally (NTP 1991).
The most frequently induced tumors were found in the oral and forestomach
mucosa, suggesting local reactivity, in addition to systemic reactivity. As
discussed in Section 2.8.3, there is evidence that 1,2,3-trichloropropane is
metabolized to reactive intermediates that can bind to DNA (Weber and Sipes
1988). Since these intermediates can interact with DNA, and respiratory
effects of inhaled 1,2,3-trichloropropane could be due to local reactivity, it
is reasonable to assume that prolonged inhalation exposure to 1,2,3-
trichloropropane would produce local and systemic tumors. An inhalation bioassay
would be useful to confirm this expectation and to determine the airborne
concentrations necessary to produce a carcinogenic response. 1,2,3-
Trichloropropane could also be tested to determine whether it is carcinogenic by
the dermal route.
Genotoxicity. Information on the genotoxicity of 1,2,3-trichloropropane
in humans is not available. The genotoxicity of 1,2,3-trichloropropane has
been evaluated in several assays that provide limited evidence of mutagenicity
in bacteria and clastogenicity (sister chromatid exchanges) in cultured
hamster cells (Haworth et al. 1983; Ratpan and Plaumann 1988; Stolzenberg and
Hine 1980; Von der Hude et al. 1987). 1,2,3-Trichloropropane did not induce
dominant lethal mutations in rats exposed orally for 5 days (Saito-Suzuki et
al. 1982). Additional studies in mammalian cells in vitro and in animals
would more fully characterize the genotoxicity of 1,2,3-trichloropropane.
Reproductive Toxicity. Information on reproductive effects of
1,2,3-trichloropropane in humans is not available. There were no reproductive
effects in rats exposed to a moderately high oral dose for 5 days or by
inhalation to a relatively low concentration (near the lowest concentrations
producing respiratory effects) for 10 weeks prior to mating (Johannsen et al.
1988; Saito-Suzuki et al. 1982). Oral exposure to lethal doses for 4 months
caused decreased testes and epididymis weights and no effects on testicular
histology or sperm in rats and mice, but reproductive function was not
evaluated (NTP 1983a, 1983b). Inhalation exposure to lethal concentrations of
1,2,3-trichloropropane for 4 weeks caused decreased testes and ovary weights
in rats, but reproductive organ histology and sperm and reproductive function
were not evaluated (Johannsen et al. 1988). Insufficient toxicokinetic data
are available to determine if 1,2,3-trichloropropane is likely to produce
similar reproductive effects by different routes of exposure. Evaluation of
reproductive function in animals following prolonged low dose oral exposure
and inhalation exposure at high (near maximum tolerated) concentrations,
therefore, would more fully assess the potential reproductive toxicity of
1,2,3-trichloropropane. Multigeneration or continuous-breeding studies in
animals would provide a better basis for evaluating reproductive toxicity but
may not be desirable unless other studies indicate that the reproductive
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system is a target organ. Reproductive toxicity data are particularly
desirable prior to developing MRLs.
Developmental Toxicity. Information on the developmental toxicity of
1,2,3-trichloropropane in humans is not available. There were no effects on
growth or viability of offspring of rats exposed by inhalation to low
concentrations of 1,2,3-trichloropropane prior to mating and during gestation,
but teratogenicity was not evaluated (Johannsen et al. 1988). 1,2,3-
Trichloropropane was not teratogenic in rats treated by intraperitoneal
injection (Hardin et al. 1981). Insufficient toxicokinetic data are available
to determine if 1,2,3-trichloropropane is likely to produce similar
developmental effects by different routes of exposure. Additional evaluations
using natural routes of exposure and higher doses, particularly inhalation and
oral teratogenicity studies, would more fully evaluate the developmental
toxicity potential of 1,2,3-trichloropropane. Developmental toxicity data are
particularly desirable prior to developing MRLs.
Immunotoxicity. Information on the immunological effects of
1,2,3-trichloropropane in humans is not available. Effects such as lymphoid
depletion and decreased weight of the spleen of rats and mice exposed orally
and by inhalation to near-lethal levels of 1,2,3-trichloropropane for several
weeks could have immunological significance (Johannsen et al. 1988; NTP
1983a). Limited evidence from one study suggests that 1,2,3-trichloropropane
may be a weak dermal sensitizer in guinea pigs (Clark 1977). The only other
skin sensitization study of 1,2,3-trichloropropane (Alpert 1982), also
performed with guinea pigs, was negative and provides evidence that the
vehicle may have accounted for the effect observed by Clark (1977).
Sensitization by 1,2,3-trichloropropane from other routes of exposure has not
been evaluated. Immunoassays and additional sensitization tests would help
assess the immunotoxic potential of 1,2,3-trichloropropane.
Neurotoxicity. Information on the neurological effects of
1,2,3-trichloropropane in humans is not available. Signs suggestive of CNS
impairment occur only in animals exposed to acute lethal levels of
1,2,3-trichloropropane by the inhalation, oral, and dermal routes (Alpert
1982; Clark 1977; Gushow and Quast 1984; Union Carbide 1958), but these do not
necessarily indicate that 1,2,3-trichloropropane is neurotoxic because they
could be due to other causes in dying animals. There is evidence that
exposure to 1,2,3-trichloropropane does not cause histopathological lesions in
the CNS (Johannsen et al. 1988; Miller et al. 1986a; NTP 1983a, 1983b), but
this does not necessarily indicate that 1,2,3-trichloropropane is
nonneurotoxic because behavioral, neurochemical, and neurophysiological
examinations were not performed. Overall, there is evidence that
neurotoxicity is a critical effect of 1,2,3-trichloropropane.
Epidemiological and Human Dosimetry Studies. Health effects of
1,2,3-trichloropropane in humans have only been described as a consequence of
intentional vapor exposure in a study of sensory response. As indicated in
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Chapter 5, there is probably no identifiable subpopulation with exclusive or
predominant exposure to 1,2,3-trichloropropane in the general populace or
workplace. If such a population is identified, excreted 1,2,3-trichloropropane
or its metabolites could probably be correlated with exposure or health
effects. Metabolites specifically attributable to 1,2,3-trichloropropane,
however, are presently unknown.
Biomarkers of Exposure and Effect. There are no known biomarkers of
exposure for 1,2,3-trichloropropane in humans. Studies with rats suggest that
respiratory or urinary excretion of 1,2,3-trichloropropane may be sufficient
for monitoring purposes (Sipes et al. 1982). Additional studies could help
determine the feasibility of using 1,2,3-trichloropropane in the breath or
urine as a biomarker of exposure. Mild anemia and alterations in liverassociated
serum enzymes occurred in rats treated with 1,2,3-trichloropropane
(NTP 1983a) but are not useful as biomarkers of exposure because they can be
due to many causes and might not occur in humans. Information on effects
specific for 1,2,3-trichloropropane would be helpful for developing a
biomarker of exposure for 1,2,3-trichloropropane.
There are no known biomarkers of effects for 1,2,3-trichloropropane in
humans. One study with rats (NTP 1983a) suggests that anemia and alterations
of serum enzymes (e.g., decreased serum pseudocholinesterase activity) might
be sensitive biomarkers for hematologic and hepatic effects of 1,2,3-
trichloropropane, respectively. Additional animal studies or examination of humans
with known exposure to 1,2,3-trichloropropane would help determine if 1,2,3-
trichloropropane is likely to cause anemia or consistent serum enzyme alterations
in humans.
Absorption, Distribution, Metabolism, and Excretion. There is limited
information on absorption and excretion of single oral doses of
1,2,3-trichloropropane in rats (Sipes et al. 1982; Volp et al. 1984), but no
data are available on the toxicokinetics of 1,2,3-trichloropropane in animals
after inhalation or dermal exposure. Tissue distribution, metabolism, and
excretion of intravenously injected 1,2,3-trichloropropane also have been
investigated in rats (Volp et al. 1984). A physiologically based
pharmacokinetic model describing tissue distribution and excretion was
developed using data from this intravenous study. A more complete oral study
in animals, as well as animal studies using inhalation and dermal exposure,
could provide necessary data (e.g., absorption kinetics) for expanding the
model to include inhalation, oral, and dermal exposure and verifying the
model. It might then be possible to use the model to predict the
pharmacokinetics of 1,2,3-trichloropropane in humans exposed by these routes.
Studies with several dose levels and exposure durations would allow more
accurate comparison between routes (e.g., assessment of relative rates and
extent of absorption, ,distribution, metabolism, and excretion) as well as
detection of saturation effects.
51
2. HEALTH EFFECTS
Comparative Toxicokinetics. The toxicokinetics of 1,2,3-trichloropropane
have been studied only in rats by the oral and intravenous routes (Sipes et al.
1982; Volp et al. 1984). A physiologically based pharmacokinetic model has been
proposed based on the intravenous data. Studies in other species would be useful
for verifying predictions made from the model about other species, including
humans.
Mitigation of Effects. Based on limited toxicokinetic data for
1,2,3-trichloropropane and information on the metabolism of other halogenated
alkanes, it is anticipated that 1,2,3-trichloropropane can undergo
dehalogenation reactions catalyzed by microsomal mixed function oxidases.
Depending on the reaction mechanism(s), reactive intermediates could be
formed. Also it is possible that 1,2,3-trichloropropane itself contributes to
toxicity. Studies elucidating the mechanism of action and identity of
reactive intermediates of 1,2,3-trichloropropane would be useful in planning
research aimed at developing agents that could interfere with the mechanism of
toxicity, thereby mitigating the effects.
2.9.3 On-going Studies
A bioassasy in which rats and mice were treated by gavage for 2 years
has been completed and recently approved (NTP 1991). The doses of 1,2,3-
trichloropropane used in the bioassay were 0, 3, 10, and 30 mg/kg in
rats and 0, 6, 20, and 60 mg/kg in mice (Burka 1990a). Preliminary results
indicate that treatment resulted in increased incidences of tumors in both
species (Mahmood et al. 1988; Weber and Sipes 1988).
The final report of an NTP continuous-breeding study is in preparation
(Burka 1990b).
The results of a metabolism and mutagenicity study of 1,2,3-
trichloropropanehave been reported as an abstract (Mahmood et al. 1988). Rats that
were administered 30 mg/kg of 14C-1,2,3-trichloropropane by gavage excreted
approximately 50%, 20%, and 20% of the radioactivity in the urine, feces, and
as carbon dioxide, respectively, in the following 60 hours. Two urinary
metabolites were identified as N-acetyl-S-(3-chloro-2-hydroxypropyl) cysteine
and 3-chloro-2-hydroxypropyl cysteine. Radioactivity was most concentrated in
the liver, kidney, and forestomach. 1,2,3-Trichloropropane was mutagenic in
Salmonella typhimurium TA100 in the Ames assay only in the presence of S9 or
microsomes, and mutagenicity decreased upon addition of glutathione. The
urine from the treated rats or synthetic N-acetyl-S-(3-chloro-2-hydroxypropyl)
cysteine were not mutagenic in this assay.
Rats were administered a 30 mg/kg dose of 14C-1,2,3-trichloropropane by
intraperitoneal injection in a preliminary investigation into the role of
biotransformation in 1,2,3-trichloropropane-induced tumor formation (Weber and
Sipes 1988). Covalent binding to hepatic protein and DNA was demonstrated,
suggesting that 1,2,3-trichloropropane is genotoxic. In vitro studies,
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however, showed that glutathione decreased protein binding and increased the
formation of water-soluble 14C-1,2,3-trichloropropane equivalents, and that
there was no significant covalent binding of 1,2,3-trichloropropane to DNA.
The in vitro data indicated that the role of biotransformation in
1,2,3-trichloropropane-induced genotoxicity is still unclear.
The results of an investigation of the cardiotoxic and hepatic effects
of 1,2,3-trichloropropane were reported in an abstract (Robinson et al. 1989).
Rats were administered various doses of 1,2,3-trichloropropane by gavage for
durations ranging from 1 to 10 days. Doses of 0.2, 0.4, 0.6, and 0.8 mmol/kg
(29.5-117.9 mg/kg) produced myocardial necrosis in 0%, 0%, 10%, and 80% of the
rats, respectively. This effect was observed after 6 days of treatment at
0.8 mmol/kg (117.9 mg/kg). Doses of 1.6-2.8 mmol/kg (235.9-412.8 mg/kg)
caused increasing hepatotoxicity and eventual death but no myocardial
necrosis. Tissue levels of 1,2,3-trichloropropane were markedly increased
after 10 days compared to l-day exposure, suggesting bioaccumulation.
Peripheral catecholamine depletion with 6-hydroxydopamine reduced myocardial
necrosis from moderate to minimum severity. The results of this study
suggested that dose and time of 1,2,3-trichloropropane exposure determine the
appearance of heart or liver toxicity, and that cardiotoxic effects of
1,2,3-trichloropropane may involve bioaccumulation and sympathoadrenergic
factors.
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3. CHEMICAL AND PHYSICAL INFORMATION
3.1 CHEMICAL IDENTITY
Data pertaining to the chemical identity of 1,2,3-trichloropropane are
listed in Table 3-1.
3.2 PHYSICAL AND CHEMICAL PROPERTIES
The physical and chemical properties of 1,2,3-trichloropropane are
presented in Table 3-2.
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4. PRODUCTION, IMPORT, USE, AND DISPOSAL
4.1 PRODUCTION
Recent data regarding production volumes for 1,2,3-trichloropropane are
not available. The estimated 1977 production volume for the chemical ranged
from 21 to 110 million pounds (EPA 1989b). Current manufacturers of
1,2,3-trichloropropane include Dow Chemical U.S.A., Freeport, Texas, and Shell
Oil Company, Deer Park, Texas (SRI 1989). In 1977, two additional manufacturing
locations were Dow Chemical U.S.A., a major producer in Midland, Michigan, and
Columbia Organic Chemicals Co., a minor producer in Columbia, South Carolina (EPA
1989b). 1,2,3-Trichloropropane can be produced via the chlorination of propylene
(Hawley 1981). Other reported methods for producing 1,2,3-trichloropropane include
the addition of chlorine to ally1 chloride, reaction of thionyl chloride with
glycerol, and the reaction of phosphorus pentachloride with either 1,3- or 2,3-
dichloropropanol (NIOSH 1981; Williams 1949). 1,2,3-Trichloropropane also may be
produced in potentially significant amounts as a byproduct of processes primarily
used to produce other chemicals, including dichloropropene (a soil fumigant and
nematocide), propylene chlorohydrin, propylene oxide, dichlorohydrin, and glycerol
(Baier et al. 1987; NIOSH 1981). Technical-grade 1,2,3-trichloropropane reportedly
varies between 97.5% and 99.4% purity (Alberti 1982; NTP 1983a). The material
tested by the NTP (1983a) contains the following impurities: 0.066% water, 0.14%
unspecified chlorohexene, two unspecified chlorohexadienes (0.24% and 0.13%),
and total acidity of 48 ppm (as HCl).
4.2 IMPORT/EXPORT
No data concerning the import or export of 1,2,3-trichloropropane were
located.
4.3 USE
1,2,3-Trichloropropane has, in the past, been used mainly as a solvent
and extractive agent. No current information is available that indicates that
the compound is still used for these purposes today. It dissolves a variety
of resins, oils, waxes, and other materials while having a low solubility in
water (Williams 1949). Common uses have included use as a paint- and varnish-
remover, a cleaning and degreasing agent, and a cleaning and maintenance
reagent (Hawley 1981; NIOSH 1981). Currently, it is used as a chemical
intermediate, for example, in the production of polysulfone liquid polymers
and dichloropropene, synthesis of hexafluoropropylene, and as a crosslinking
agent in the synthesis of polysulfides (Baier et al. 1987; Ellerstein and
Bertozzi 1982; Gangal 1980; HSDB 1989). No data were found concerning the
approximate amounts currently used for particular purposes.
4.4 DISPOSAL
1,2,3-Trichloropropane has been identified as a hazardous waste by the
EPA, and the disposal of this compound is regulated under the Resource
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Conservation and Recovery Act (RCRA). Specific information regarding the
federal regulations of land disposal of 1,2,3-trichloropropane is available
(EPA 1988a). 1,2,3-Trichloropropane can be disposed of via atomization in a
suitable incinerator equipped with appropriate effluent gas scrubbers (HSDB
1989). In case of accidental spills, the chemical may be disposed of by
absorption onto vermiculite, dry sand, earth, or similar material followed by
disposal in a secured landfill (HSDB 1989); however, land disposal may no
longer be allowed by the disposal regulations discussed above. Significant
removal of 1,2,3-trichloropropane from waste water and sewage may be
accomplished through the use of activated sludge treatment processes (Matsui
et al. 1975). No data were found concerning the approximate amounts disposed
by the various methods.
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5.1 OVERVIEW
1,2,3-Trichloropropane is a man-made chemical that is present in the
environment as a result of anthropogenic activity. Releases to the
environment are likely to occur as a result of its manufacture, formulation,
and use as a solvent and extractive agent, paint- and varnish-remover,
cleaning and degreasing agent, cleaning and maintenance reagent, and chemical
intermediate (HSDB 1989). Releases may occur as a result of the disposal of
wastes from production of 1,2,3-trichloropropane and disposal of products that
contain the chemical, especially at hazardous waste sites that received
1,2,3-trichloropropane-containing wastes. Release to soil can occur through
the use of certain soil fumigants and nematocides that are known to contain
1,2,3-trichloropropane as an impurity and through the disposal of
1,2,3-trichloropropane-containing sewage sludge from municipal sewage
treatment plants.
In ambient air, the primary removal process is expected to be the vaporphase
reaction with photochemically generated hydroxyl radicals. In surface
waters, the primary removal process is likely to be volatilization. In soil,
the primary removal processes are volatilization from near-surface soil and
leaching to groundwater. Aerobic biodegradation is probably a slow process in
natural waters and soil. It may persist in groundwater for a relatively long
time.
Data regarding the concentrations of 1,2,3-trichloropropane in the
environment are limited, but concentrations should not be large except in case
of an accidental spill. It has been found at low levels in the United States
in a few rivers and bays, drinking water, groundwater, and hazardous waste
sites. The EPA has identified 1,177 NPL sites. 1,2,3-Trichloropropane has
been found at eight of the sites evaluated for the presence of this chemical.
However, we do not know how many of the 1,177 NPL sites have been evaluated
for this chemical. As more sites are evaluated by EPA, the number may change.
The frequency of these sites within the United States can be seen in
Figure 5.1.
The general population can be exposed to low levels of 1,2,3-
trichloropropane mainly by ingesting contaminated water. Members of the general
population living near waste sites that contain 1,2,3-trichloropropane may be
exposed to low levels of 1,2,3-trichloropropane in their drinking water if they
obtain their household water from a well. Additional exposure may occur through
the inhalation of contaminated air, especially for those who live near facilities
that manufacture or use 1,2,3-trichloropropane or at treatment or disposal
facilities. Inhalation and dermal exposure may occur during the use of consumer
products containing 1,2,3-trichloropropane, such as certain paint removers. It is
difficult to assess the extent of general population and occupational exposure
because data are lacking. However, significant exposure to 1,2,3-trichloropropane
may be unlikely because the compound may no longer be used for purposes other than
a chemical intermediate, and current
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manufacturing processes generally occur in closed and tightly sealed systems
(NIOSH 1981). The National Occupational Exposure Survey (NOES) conducted by
NIOSH from 1981 to 1983 statistically estimated that 492 workers are
potentially exposed to 1,2,3-trichloropropane in the United States. The NOES
database does not contain information on the frequency, concentration, or
duration of exposure of workers to any of the chemicals listed therein. This
summary provides only estimates of the number of workers potentially exposed
to chemicals in the workplace. Occupational exposure probably results from
inhalation and dermal contact.
5.2 RELEASES TO THE ENVIRONMENT
5.2.1 Air
Data on releases of 1,2,3-trichloropropane to the atmosphere are
lacking. Based on the few data available, current releases to the air are
expected to be relatively small. Minor releases may have occurred as exhaust,
stack, and fugitive emissions from its manufacture, formulation, and use as a
solvent (HSDB 1989). 1,2,3-Trichloropropane may have been released in the
past into the air as a result of its use as a paint- and varnish-remover, a
degreasing agent, and a cleaning and maintenance reagent (Hawley 1981; NIOSH
1981). No information was found that indicates that 1,2,3-trichloropropane is
still used for these purposes today. Very small amounts may be released
during its use as a chemical intermediate and as a result of its formation
during the synthesis of other organic chemicals (see Section 4.1).
Volatilization from contaminated surface waters, effluent waters, and near-
surface soils may also be minor atmospheric sources of this compound. This
includes volatilization from identified and unidentified hazardous waste dumps
that contain 1,2,3-trichloropropane and from farmland treated with
1,2,3-trichloropropane-contaminated fumigants and nematocides (no information
is available to determine whether or not the soil fumigants and nematocides
currently manufactured contain 1,2,3-trichloropropane). Small amounts may be
released to the air during treatment of water containing
1,2,3-trichloropropane, because some of the chemical may be removed via
evaporative stripping from the water.
5.2.2 Water
Data on the release of 1,2,3-trichloropropane to environmental waters
are lacking. Based on the few data available, current releases to
environmental waters are expected to be relatively small. Releases to surface
water may have occurred through runoff of waste water from hazardous waste
sites containing 1,2,3-trichloropropane and runoff from farmland treated with
certain soil fumigants and nematocides that contain 1,2,3-trichloropropane.
Releases to surface and groundwater may have occurred as a result of the
improper disposal of 1,2,3-trichloropropane-containing industrial wastes or
wastes from its use in paint- and varnish-removers, cleaning and degreasing
agents, and maintenance reagents. Releases to groundwater may have occurred
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as a result of the chemical leaching through soil at waste sites and
agricultural soil treated with fumigants that contain the chemical. Small
amounts of the chemical may have entered surface waters as a result of washout
from 1,2,3-trichloropropane-contaminated air; however, some of the
1,2,3-trichloropropane removed from the atmosphere by washout is likely to
have re-entered the atmosphere by volatilization. The chemical was found in
groundwater at 0.71% of the sites in the Contract Laboratory Program
Statistical Database (CLPSD) at a geometric mean concentration of 57.3 µg/L
(CLPSD 1989). Note that the CLPSD includes data from both NPL and non-NPL
sites.
5.2.3 Soil
Data on releases of 1,2,3-trichloropropane to soils are sparse, which
makes a quantitative estimation of the magnitude of such releases impossible.
However, releases to soils are expected to be relatively small based upon the
available data. Releases to farmland soil have occurred as a result of the
use of certain soil fumigants and nematocides known to contain
1,2,3-trichloropropane as an impurity. No current information is available,
however, that indicates that these soil fumigants and nematocides still
contain 1,2,3-trichloropropane. Releases of the chemical to soil may have
occurred as a result of disposal of 1,2,3-trichloropropane-containing sewage
sludge from municipal sewage treatment plants (Jacobs and Zabik 1983). Very
small amounts of the chemical may be brought to the surface of the earth as a
result of washout from 1,2,3-trichloropropane-containing air; however, much of
the 1,2,3-trichloropropane removed from the atmosphere by washout may re-enter
the atmosphere by volatilization from near-surface soil. Land disposal of
wastes from its use in paint- and varnish-removers, cleaning and degreasing
agents, and cleaning and maintenance reagents may have released
1,2,3-trichloropropane to soil. The chemical was found in soil at 0.71% of
the sites in the CLPSD at a geometric mean concentration of 204 µg/kg (CLPSD
1989). Note that the CLPSD includes data from both NPL and non-NPL sites.
5.3 ENVIRONMENTAL FATE
5.3.1 Transport and Partitioning
No experimental or predictive data were located in the literature
regarding the transport of 1,2,3-trichloropropane in the atmosphere.
1,2,3-Trichloropropane is expected to exist in the atmosphere predominantly in
the vapor phase, based on its vapor pressure (Table 3-2) (Eisenreich et al.
1981; MacKay et al. 1982). The speculation that substantial amounts of
1,2,3-trichloropropane are not likely to be present in the particulate phase
indicates that dry deposition to the earth's surface will not be an important
removal process. Based upon its low water solubility and moderate vapor
pressure (Table 3-2), very small amounts of 1,2,3-trichloropropane present in
63
5. POTENTIAL FOR HUMAN EXPOSURE
air may be removed by wet deposition; however, much of the 1,2,3-trichloropropane
removed from the atmosphere by washout is likely to re-enter the
atmosphere by volatilization.
Based upon an estimated soil organic carbon partition coefficient (K
oc
)
of 98 (calculated from water solubility) (Lyman et al. 1982; Riddick et al.
1986), 1,2,3-trichloropropane is expected to display high mobility in soil
(Swann et al. 1983); therefore, it has the potential to leach into
groundwater. This predicted mobility is confirmed by the detection of
1,2,3-trichloropropane in groundwater from various locations (see
Section 5.4.2). The vapor pressure of 1,2,3-trichloropropane (3.1 mmHg at
25°C) (MacKay et al. 1982), and the calculated Henry's law constant
(3.17x10-4 atm-m3/mol at 25°C) (Lyman et al. 1982) suggest that volatilization
from either dry or moist soil to the atmosphere will be a significant
environmental process.
1,2,3-Trichloropropane in surface water is expected to volatilize
rapidly to the atmosphere. An experimental half-life of 56.1 minutes has been
measured for evaporation of 1,2,3-trichloropropane from a 1 ppm solution, with
a depth of 6.5 cm, stirred with a shallow pitch propeller at 200 rpm at 25°C
under still air (less than 0.2 mph air currents) (Dilling 1977). Using the
Henry's law constant, a half-life of 6.9 hours was calculated for evaporation
from a model river 1 m deep, flowing at 1 m/set, with a wind velocity of
3 m/set, and neglecting adsorption to sediment (Lyman et al. 1982). A
volatilization half-life of 3.5 days from a model pond can be estimated (EPA
1985). 1,2,3-Trichloropropane is not expected to significantly adsorb to
sediment and suspended organic matter based upon the estimated K
oc 
of 98
(calculated from water solubility) (Lyman et al. 1982; Riddick et al. 1986).
It is also not expected to significantly bioconcentrate in fish and aquatic
organisms based upon an estimated bioconcentration factor (BCF) of 9.2
(calculated from log octanol-water partition coefficient (K
ow
) (EPA 1988b;
Lyman et al. 1982). No data were located to indicate a potential for
1,2,3-trichloropropane to biomagnify from lower to higher trophic states of
the food chain, but based upon the estimated BCF, this is not likely.
5.3.2 Transformation and Degradation
5.3.2.1 Air
The primary degradation process for 1,2,3-trichloropropane in the
atmosphere is expected to occur via gas-phase reaction with photochemically
produced hydroxyl radicals. The rate constant for this process is an
estimated 1.0475x10-12 cm3/molecule-sec (Atkinson 1987). This corresponds to a
half-life of 15.3 days at an estimated atmospheric concentration of 5x105
hydroxyl radicals/cm3. Direct photolysis of 1,2,3-trichloropropane is not
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expected to occur in the atmosphere because the chemical lacks a chromophore
that absorbs light at environmentally significant wavelengths (greater than
290 nm) (Silverstein et al. 1974).
5.3.2.2 Water
Degradation of 1,2,3-trichloropropane in natural waters is expected to
be a slow process. The chemical should volatilize from surface waters before
significant degradation can occur. Hydrolysis of 1,2,3-trichloropropane in
natural waters is not expected to be a significant removal process. The
measured neutral and base hydrolysis rate constants at 25°C are 1.8x10-6 hour-l
and 9.9x10-4 M-1 hour-l, respectively (EPA 1988c). These rate constants
correspond to a hydrolysis half-life of 44 years over a pH range of 5-9.
Direct photolysis of 1,2,3-trichloropropane is not expected to occur in
environmental waters because the chemical lacks a chromophore that absorbs
light at environmentally significant wavelengths (greater than 290 nm)
(Silverstein et al. 1974).
No studies were located regarding the biodegradation of
1,2,3-trichloropropane in natural waters. An aqueous screening study with
activated sewage sludge has indicated that 1,2,3-trichloropropane can be
removed by biological treatment processes and that at least part of the
removal was due to volatilization. However, this study cannot be used to
predict the biodegradability of this compound under natural conditions. Other
authors have observed that halogenated hydrocarbons, in general, and
especially those with multiple chlorine substitution, such as
1,1,2-trichloroethane and 1,1,2,2-tetrachloroethane, are recalcitrant towards
biodegradation (Kawasaki 1980; Tabak et al. 1981). No data concerning the
potential for anaerobic aqueous biodegradation of 1,2,3-trichloropropane were
found.
5.3.2.3 Soil
No data specifically regarding the degradation of 1,2,3-trichloropropane
in soil were found. However, it has been observed that 1,2-dichloropropane
will not significantly biodegrade in soil (Roberts and Stoydin 1976).
Therefore, 1,2,3-trichloropropane is expected to be even less biodegradable
because it contains an additional chlorine. The rate of 1,2,3-trichloropropane
loss from soil due to biodegradation may not be significant when compared with its
loss by volatilization and leaching from soil. 1,2,3-Trichloropropane will be lost
from the soil by evaporation (from both moist and dry near-surface soil) and by
leaching to groundwater before 1,2,3-trichloropropane will hydrolyze in soil.
Direct photolysis on the surface of soil will not occur.
65
5. POTENTIAL FOR HUMAN EXPOSURE
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1 Air
No data were located regarding the detection of 1,2,3-trichloropropane
in ambient air in the United States. Therefore, no estimate of U.S.
atmospheric levels of the chemical, including background levels, is possible.
5.4.2 Water
Limited data are available regarding the detection of
1,2,3-trichloropropane in environmental waters. It has been detected by one
of the sampling techniques at less than 0.2 µg/L in drinking water from the
Carrollton Water Plant in New Orleans, Louisiana, sampled during August, 1974;
however, since two of the three sampling techniques failed to detect the
compound, the significance of this detection is in question (Keith et al.
1976). 1,2,3-Trichloropropane has been qualitatively detected in the drinking
water of Cincinnati, Ohio, sampled during 1978 (EPA 1984), and Ames, Iowa, on
an unspecified date (EPA 1987). Data from the EPA STORET Data Base indicate
that 1,2,3-trichloropropane was found in 39% of 941 samples of groundwater at
a median concentration of 0.69 µg/L, at an average concentration of 1.0 µg/L,
and a range of trace (below unspecified detection limit) to 2.5 µg/L (STORET
1989). It has been found at concentrations ranging from 0.1 to 5.0 µg/L in
groundwater samples from California and Hawaii during small- and large-scale
retrospective studies of farmlands possibly treated with fumigants and
nematocides that contained 1,2,3-trichloropropane as an impurity (Cohen et al.
1986, 1987). The locations that had 1,2,3-trichloropropane-contaminated wells
included the island of Oahu, Hawaii, and the Central Valley of California.
Typical concentrations ranged from 0.2 to 2 µg/L. 1,2,3-Trichloropropane was
found in water from nine of nine wells in Oahu, Hawaii, sampled in 1983 and
1984 at maximum concentrations ranging from 0.30 to 2.8 µg/L (Oki and
Giambelluca 1987). The wells had been closed previously to drinking water use
due to contamination with other halogenated hydrocarbons.1,2,3-
Trichloropropane has been detected in groundwater from 2 of 10 sites in
an agricultural community in Suffolk County, New York, at concentrations of 6
and 10 µg /L (Lykins and Baier 1985).
1,2,3-Trichloropropane was qualitatively found in 1 of 30 water samples
from the Delaware, Schuylkill, and Lehigh Rivers, taken February 17-20, 1976
(DeWalle and Chian 1978). 1,2,3-Trichloropropane was qualitatively found in
water from Narragansett Bay, Rhode Island, sampled during the summers of 1979
and 1980, and the winters of 1980 and 1981 (Wakeham et al. 1983). Some
samples reportedly contained significant levels of the chemical. The chemical
was qualitatively detected in effluent from an advanced waste treatment plant
in Lake Tahoe, California, in 1974 (EPA 1984). The chemical was found in
groundwater at 0.71% of the sites in the CLPSD, which includes data from both
NPL and non-NPL sites, at a geometric mean concentration of 57.3 µg/L (CLPSD
1989). 1,2,3-Trichloropropane was found in 69 of 141 samples of sewage
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sludges from municipal sewage treatment plants in Michigan in 1980 (Jacobs and
Zabik 1983). The median and average concentrations of 1,2,3-trichloropropane
in the sludges were 0.352 and 1.07 mg/kg, respectively, and the range was
0.00459-19.5 mg/kg on a dry-weight basis.
5.4.3 Soil
Limited data are available regarding the detection of 1,2,3-trichloropropane
in soil samples. It has been found in soil samples from California and Hawaii
during small- and large-scale retrospective studies at levels typically ranging
from 0.2 to 2 ppb (Cohen et al. 1987). It was found at least 10 feet down in the
soil profiles in Hawaii. 1,2,3-Trichloropropane may be present in these soils as a
result of the use of dichloropropene (a soil fumigant and nematocide). 1,2,3-
Trichloropropane is used in the preparation of this nematocide and is an impurity
in the formulation of it (Baier et al. 1987). 1,2,3-Trichloropropane was not found
in any of the soil samples from the sites in the CLPSD (1988). The detection
of the chemical in the groundwater of hazardous waste sites, however, suggests
that it is released to soil at these sites. The chemical was found in soil at
0.71% of the sites of the CLPSD at a geometric mean concentration of 204 pg/L
(CLPSD 1989); the CLPSD includes data from both NPL and non-NPL sites.
5.4.4 Other Environmental Media
1,2,3-Trichloropropane has been qualitatively identified as a component
of ethylene dichloride-tar, a tarlike, oily waste byproduct of vinyl chloride
production that had been disposed of by dumping into the sea (Jensen et al.
1975). The chemical has been found in the volatile products from the thermal
oxidative degradation of the flame-retardant plasticizer, tris(dichloropropy1)
phosphate (Christos et al. 1977). No information was found that indicated
that 1,2,3-trichloropropane has been found in food. Because of the lack of
recent comprehensive monitoring data, the average daily intake of
i,2,3-trichloropropane and the relative significance of each source of
exposure cannot be determined.
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
There are not enough measured data to assess the general population's
exposure to this compound. The paucity of data may be the result of either a
lack of 1,2,3-trichloropropane contamination in the environment or a lack of
studies that attempt to identify and quantify the compound in the environment
using sufficiently sensitive techniques. Based upon the few data available,
the estimated transport and partitioning properties of the compound, and
information on production and use, the following estimations concerning
exposure can be made. A small part of the population may be exposed to very
low levels of 1,2,3-trichloropropane through the ingestion of contaminated
drinking water. Exposure to very low levels of 1,2,3-trichloropropane also
may occur through the inhalation of contaminated air; however, no monitoring
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data regarding the presence of 1,2,3-trichloropropane in the atmosphere in the
United States were located. General exposure to air containing low levels may
occur near chemical manufacturing facilities that produce 1,2,3-trichloropropane
and certain other chemicals, near 1,2,3-trichloropropane-containing
hazardous waste dumps, and farmlands treated with fumigants and nematocides
that contain 1,2,3-trichloropropane. No current information is available,
however, that indicates that 1,2,3-trichloropropane is still present in soil
fumigant formulations, and commercial manufacturing processes generally occur
in closed and tightly sealed systems (NIOSH 1981). Inhalation and dermal
exposure may occur during the use of 1,2,3-trichloropropane as a solvent and
extractive agent, in paint- and varnish-removers, in cleaning and degreasing
agents, and in cleaning and maintenance reagents, although there is no current
information that indicates that the compound is still used for these purposes
(Hawley 1981; NIOSH 1981). No data regarding the detection of
1,2,3-trichloropropane in humans in the United States were located.
According to the NOES conducted by NIOSH from 1981 to 1983, 492 workers
(of which 9 were women) were potentially exposed to 1,2,3-trichloropropane in
the workplace in 1980 (NIOSH 1989); however, no report of actual measured
exposure levels in any occupational situation in the United States was
located. The NOES database does not contain information on the frequency,
concentration, or duration of exposure of workers to any of the chemicals
therein. This survey provides only an estimate of the number of workers
potentially exposed to chemicals in the workplace. Occupational exposure to
1,2,3-trichloropropane is expected to be higher in facilities where the
chemical or products containing the chemical are used than in facilities that
produce 1,2,3-trichloropropane either directly or as a byproduct, since the
commercial manufacturing processes generally occur in closed and tightly
sealed systems (NIOSH 1981). Furthermore, exposure may result from procedures
that require direct handling of the material; these include purification,
formulation of products, sampling and quality control, packaging and storage,
leakage of equipment, startup and shutdown procedures, maintenance, cleanup,
spills, and other plant emergencies (NIOSH 1981).
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
Data regarding the presence of 1,2,3-trichloropropane in the environment
are lacking, which prevents the thorough assessment of the potential for high
exposure in various populations. Populations with potentially high exposure
to 1,2,3-trichloropropane will generally include those that may be exposed to
environmental contamination over long periods of time. These may include
populations exposed to low levels of 1,2,3-trichloropropane via inhalation of
contaminated air at or near both identified and unidentified
1,2,3-trichloropropane-containing waste disposal sites and landfills.
Children playing in and around these sites may also be dermally exposed to
soil containing 1,2,3-trichloropropane, although any 1,2,3-trichloropropane il
surface soil would be expected to volatilize or leach through the soil.
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Persons whose drinking water is derived from 1,2,3-trichloropropanecontaminated
groundwater or surface water for a long period of time may be
exposed to relatively high levels of 1,2,3-trichloropropane. Workers involved
in the manufacture or use of 1,2,3-trichloropropane or 1,2,3-
trichloropropanecontaining products may have the highest potential for exposure to
1,2,3-trichloropropane. Potentially high general population exposure may
occur during the use of 1,2,3-trichloropropane-containing products, such as
paint- and varnish-removers and cleaners, especially when they are used in
poorly ventilated areas such as in the cleaning of reactors. Exposure through
the manufacture or use of 1,2,3-trichloropropane-containing products may not
be significant, however, since current manufacturing processes generally occur
in closed and tightly sealed systems (NIOSH 1981) and no current information
indicates that 1,2,3-trichloropropane is still used for those purposes listed.
5.7 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA as amended directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of 1,2,3-trichloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required
to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of 1,2,3-trichloropropane. The following categories of possible data
needs have been identified by a joint team of scientists from ATSDR, NTP, and EPA.
They are defined as substance-specific informational needs that, if met, would
reduce or eliminate the uncertainties of human health assessment. In the future,
the identified data needs will be evaluated and prioritized, and a substance-
specific research agenda will be proposed.
5.7.1 Data Needs
Physical and Chemical Properties. Physical and chemical property data
are essential for estimating the transport and partitioning of a chemical in
the environment. Many of the physical and chemical properties of
1,2,3-trichloropropane are available (Table 3-2) (Hawley 1981; HSDB 1989;
Mackay et al. 1982; McNeil1 1979; Riddick et al. 1986; Ruth 1986; Weast 1985;
Williams 1949). However, only estimated values are listed for the log K
ow
,
K
oc
, and BCF (Lyman et al. 1982). Since the log K
ow 
was used to estimate the
K
oc
 and BCF, an experimentally determined log K
ow
 would lead to less
uncertainty in those estimated properties. Experimentally determined values
would remove any doubt regarding the reliability of these data, although the
techniques used for the estimations appear to be accurate.
Production, Import/Export, Use, and Disposal. Data regarding the
production methods for 1,2,3-trichloropropane are available (Bauer et al.
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1987; Hawley 1981; NIOSH 1981; SRI 1989; Williams 1949); however, data
regarding current production, import, and export volumes, and use patterns are
lacking. We do know that the chemical is currently produced (SRI 1989), but
not in what quantities or whether future production levels will increase, We
do not know if the chemical is widely used in the home, the environment, or in
the workplace, but it does not appear that such widespread use is likely. It
has not been found in food although foods may not have been tested for its
presence. Use, release, and disposal information is useful for determining
where environmental exposure to 1,2,3-trichloropropane may be high, and may
help in estimating whether exposure is likely, and therefore may help to
determine whether further toxicological studies are warranted. General data
are available regarding the methods of disposal of 1,2,3-trichloropropane
(HSDB 1989; Matsui et al. 1975), but information concerning the efficiencies
of these methods, as well as the amount disposed of by each method is lacking.
Specific disposal information, obtainable by polling industries or industry
organizations, may be useful for determining environmental burden and
potential concentrations where environmental exposures may be high. Rules and
regulations governing land disposal of 1,2,3-trichloropropane are known (EPA
1988a).
Environmental Fate. The environmental fate of 1,2,3-trichloropropane
remains unclear due to a lack of experimental data. We do not know where the
chemical partitions in the environment. However, based upon estimated
physical properties (Lyman et al. 1982), the chemical is expected to partition
into the atmosphere and groundwater (Swann et al. 1983). It has been shown
that the chemical leaches through soil (Cohen et al. 1986, 1987; Lykins and
Baier 1985; Oki and Giamelluca 1987; STORET 1989). It is estimated that it
can volatilize ,through near-surface soil and water to the atmosphere (EPA
1985; Lyman et al. 1982). Nothing definitive is known about the
biodegradability of the compound. The rate constant for reaction with
hydroxyl radicals in the atmosphere is an estimated value (Atkinson 1987), as
are significant partition coefficient values used in predicting the
environmental fate of the compound (EPA 1988b). Experimental data in these
areas would aid in assessing the ultimate environmental fate of
1,2,3-trichloropropane, which would, in turn aid in assessing its background
levels in the environment and levels of human exposure.
Bioavailability from Environmental Media. Studies have shown that
1,2,3-trichloropropane is absorbed through the lungs, gastrointestinal tract,
and skin of animals (see Section 2.3.1) (Alpert 1982; Clark 1977; Johannsen
et al. 1988; Sipes et al. 1982; Union Carbide 1958; Volp et al. 1984). This
indicates that it may be absorbed through the inhalation of contaminated air,
ingestion of contaminated water, food, and soil, and through dermal contact.
The amount of 1,2,3-trichloropropane that is bioavailable from each route is
not well documented, and no data were found for humans. Data on the
bioavailability of 1,2,3-trichloropropane would be helpful in assessing the
importance of environmental exposure levels.
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Food Chain Bioaccumulation. The estimated BCF for 1,2,3-trichloropropane
(EPA 1988b; Lyman et al. 1982) indicates that this compound would not
significantly bioconcentrate in plants, aquatic organisms, or animals. No
experimental data were found to support this conclusion. Information was
unavailable on the biomagnification of 1,2,3-trichloropropane in food chains.
Additional information on bioconcentration by plants, aquatic organisms, and
animals and biomagnification in terrestrial and aquatic food chains could be
helpful because it might help to indicate whether the chemical biomagnifies in
food chains and thereby poses a potential for significant exposure.
Biomagnification is not likely, however, based upon the estimated BCF.
Exposure Levels in Environmental Media. Limited data were available
regarding the levels of 1,2,3-trichloropropane in the environment (Baier et
al. 1987; CLPSD 1989; Cohen et al. 1986, 1987; Dewalle and Chian 1978; EPA
1984, 1987; Jacobs and Zabik 1983; Keith et al. 1976; Lykins and Baier 1985;
Oki and Giambelluca 1987; STORET 1989; Wakeham et al. 1983). Information on
exposure to 1,2,3-trichloropropane from environmental media would be useful,
especially from drinking water derived from groundwater downgradient from
1,2,3-trichloropropane-containing hazardous waste disposal sites and other
contaminated surface waters, air near facilities that make or use products
containing the compound, and soil at waste disposal sites. Data concerning
the presence of 1,2,3-trichloropropane in foods would also be useful in
assessing potential exposure.
Exposure Levels in Humans. No data have been found that indicate that
1,2,3-trichloropropane has been found in human samples of blood, urine, fat,
or breast milk. Furthermore, no biomarkers of exposure or effect have been
identified. Data on both workplace exposure and ambient environmental
exposure are sparse and outdated (NIOSH 1981; 1989). A detailed, recent
database of exposure would be helpful in determining the current exposure
levels, thus allowing estimation of the average daily dose associated with
various scenarios such as living near a hazardous waste disposal site,
drinking contaminated drinking water, or working in a contaminated workplace.
This database of exposure may be very useful if current use patterns, for
which information is not available, warrant it.
Exposure Registries. No exposure registries for 1,2,3-trichloropropane
were located. This compound is not currently one of the compounds for which a
subregistry has been established in the National Exposure Registry. The
compound will be considered in the future when chemical selection is made for
subregistries to be established. The information that is amassed in the
National Exposure Registry facilitates the epidemiological research needed to
assess adverse health outcomes that may be related to the exposure to this
compound.
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5.7.2 On-going Studies
Remedial investigations and feasibility studies conducted at the eight
NPL sites known to be contaminated with 1,2,3-trichloropropane will add to the
available database on exposure levels in environmental media, exposure levels
in humans, and exposure registries and will increase the current knowledge
regarding transport and transformation of 1,2,3-trichloropropane in the
environment.
As part of the Third National Health and Nutrition Evaluation Survey
(NHANES III), the Environmental Health Laboratory Sciences Division of the
Center for Environmental Health and Injury Control, Centers for Disease
Control, will be analyzing human blood samples for 1,2,3-trichloropropane and
other volatile organic compounds. These data will indicate the frequency of
occurrence and background levels of these compounds in the general population.
No other on-going studies were located.
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The purpose of this chapter is to describe the analytical methods that
are available for detecting and/or measuring and monitoring 1,2,3-trichloropropane
in environmental media and in biological samples. The intent is not
to provide an exhaustive list of analytical methods that could be used to
detect and quantify 1,2,3-trichloropropane. Rather, the intention is to
identify well-established methods that are used as the standard methods of
analysis. Many of the analytical methods used to detect 1,2,3-trichloropropane
in environmental samples are the methods approved by federal agencies
such as EPA and the National Institute for Occupational Safety and Health
(NIOSH). Other methods presented in this chapter are those that are approved
by groups such as the Association of Official Analytical Chemists (AOAC) and
the American Public Health Association (APHA). Additionally, analytical
methods are included that refine previously used methods to obtain lower
detection limits, and/or to improve accuracy and precision.
6.1 BIOLOGICAL MATERIALS
No completed studies were located in the literature that reported the
analysis of 1,2,3-trichloropropane in human biological matrices. Methods were
located, however, for the analysis of the compound in rat biological matrices.
These methods are listed in Table 6-l. With suitable modifications, the
methods used to detect this chemical in animal samples may apply generally to
its determination in human biological samples. Section 6.2 includes a
discussion of the methods that may be most sensitive for the determination of
1,2,3-trichloropropane concentrations in environmental samples, including
advantages and disadvantages of the commonly used methods. Initial testing to
determine minimum detection limits, recovery, accuracy, and precision of the
particular, suitably modified methods is necessary to gauge the applicability
of the methods used to detect 1,2,3-trichloropropane in animal biological
samples for the chemical's determination in human biological samples.
6.2 ENVIRONMENTAL SAMPLES
Methods for analyzing 1,2,3-trichloropropane in environmental samples
are presented in Table 6-2. All of the methods listed use either adsorption
on a sorption column (air samples) or purge-and-trap methods (solid and liquid
samples), followed by thermal desorption and some form of gas chromatography
(GC) with an appropriate detector as the analytical quantification technique.
Purge-and-trap methods involve the purging of the vapor from the sample or its
suspension in water with an inert gas and the trapping of the desorbed vapors
in a sorbent trap. Particular care must be taken in sampling and storage of
samples in view of the compound's high volatility. Although 1,2,3-trichloropropane
was listed as a chemical that could be determined using the listed techniques,
significant factors such as the detection limit and percent recovery were not
reported for this chemical. Both halogen-specific detection (e.g., Hall
electrolytic conductivity detectors) and mass spectrometry (MS) provide excellent
detection limits (EPA 1986a; Ho 1989;
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Lopez-Avila et al. 1987; Ramus et al. 1984). An advantage of halogenspecific
detectors is that they are very sensitive and specific to halogen
compounds. MS, on the other hand, provides additional confirmation of the
identity of a compound through its ion fragment patterns. High-resolution gas
chromatography (HRGC) with capillary columns coupled with MS provides better
resolution and increased sensitivity for volatile compounds than packed
columns. In this method, desorbed compounds are cryogenically trapped onto
the head of the capillary column. This HRGC-MS method overcomes some common
problems involved in analyses of excessively complex samples, samples with
large ranges of concentrations, and samples that also contain nonvolatile
compounds (Dreisch and Munson 1983; EPA 1986a).
6.3 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA as amended directs the Administrator of
ATSDR (in consultation with the Administrator of EPA and agencies and programs
of the Public Health Service) to assess whether adequate information on the
health effects of 1,2,3-trichloropropane is available. Where adequate
information is not available, ATSDR, in conjunction with the NTP, is required
to assure the initiation of a program of research designed to determine the
health effects (and techniques for developing methods to determine such health
effects) of 1,2,3-trichloropropane.
The following categories of possible data needs have been identified by
a joint team of scientists from ATSDR, NTP, and EPA. They are defined as
substance-specific informational needs that, if met, would reduce or eliminate
the uncertainties of human health assessment. In the future, the identified
data needs will be evaluated and prioritized, and a substance-specific
research agenda will be proposed.
6.3.1 Data Needs
Methods for Determining Biomarkers of Exposure and Effect. No
biomarker, other than possibly 1,2,3-trichloropropane itself, that can be
associated quantitatively with exposure to 1,2,3-trichloropropane has been
identified (see Section 2.5). Even the compound itself may not be a
quantitative biomarker of exposure because the levels found have not been
proven to qualitatively reflect exposure levels. Nevertheless, there are
methods for analyzing 1,2,3-trichloropropane in most of the biological
matrices for the rat, although important information such as detection limits
and recoveries was not reported (Sipes et al. 1982). These methods may be
sufficient for the analysis of human biological matrices.
No biomarkers have been identified that can be associated quantitatively
with effects caused by exposure to 1,2,3-trichloropropane. Therefore, methods
for biomarkers of effects are not currently available.
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Methods for Determining Parent Compounds and Degradation Products in
Environmental Media. Analytical methods for determining 1,2,3-trichloropropane in
contaminated air, water, soil, liquid and solid waste, sewage sludge, and citrus
fruits are available (EPA 1986a, 1986b; Ho 1989; Lopez-Avila et al. 1987; NIOSH
1987; Tonogai et al. 1986). No methods were found for the determination of 1,2,3-
trichloropropane in sediments. Most of the methods used for environmental samples,
however, did not report detection limits, recovery, accuracy, and precision for
1,2,3-trichloropropane. Knowledge of these factors, as well as the
development of alternative methods of analysis, would help in estimating the
potential for human exposure to 1,2,3-trichloropropane. No information was
found regarding degradation products of 1,2,3-trichloropropane. Consequently,
no comment regarding the availability of analytical methods for determining
degradation products can be made.
6.3.2 On-going Studies
The Environmental Health Laboratory Sciences Division of the Center for
Environmental Health and Injury Control, Centers for Disease Control, is
developing methods for analyzing 1,2,3-trichloropropane and other volatile
organic compounds in blood. These methods use high resolution gas
chromatography and magnetic sector mass spectrometry, which gives detection
limits in the low ppt (parts per trillion) range.
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7. REGULATIONS AND ADVISORIES
National regulations and guidelines pertinent to human exposure to
1,2,3-trichloropropane are summarized in Table 7-l. Guidance from the World
Health Organization and the International Agency for Research on Cancer is not
available.
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as
specified in the Toxicological Profiles.
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed
per unit weight of organic carbon in the soil or sediment to the concentration
of the chemical in solution at equilibrium.
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or
soil (i.e., the solid phase) divided by the amount of chemical in the solution
phase, which is in equilibrium with the solid phase, at a fixed solid/solution
ratio. It is generally expressed in micrograms of chemical sorbed per gram of
soil or sediment.
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
chemical in aquatic organisms at a specific time or during a discrete time
period of exposure divided by the concentration in the surrounding water at
the same time or during the same period.
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group
of studies, that produces significant increases in the incidence of cancer (or
tumors) between the exposed population and its appropriate control.
Carcinogen -- A chemical capable of inducing cancer.
Ceiling Value -- A concentration of a substance that should not be exceeded,
even instantaneously.
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified
in the Toxicological Profiles.
Developmental Toxicity -- The occurrence of adverse effects on the developing
organism that may result from exposure to a chemical prior to conception
(either parent), during prenatal development, or postnatally to the time of
sexual maturation. Adverse developmental effects may be detected at any point
in the life span of the organism.
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
result of prenatal exposure to a chemical; the distinguishing feature between
the two terms is the stage of development during which the insult occurred.
The terms, as used here, include malformations and variations, altered growth,
and in utero death.
EPA Health Advisory -- An estimate of acceptable drinking water levels for a
chemical substance based on health effects information. A health advisory is
not a legally enforceable federal standard, but serves as technical guidance
to assist federal, state, and local officials.
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Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental
concentration of a contaminant from which one could escape within 30 min
without any escape-impairing symptoms or irreversible health effects.
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days
as specified in the Toxicological Profiles.
Immunologic Toxicity -- The occurrence of adverse effects on the immune system
that may result from exposure to environmental agents such as chemicals.
In vitro -- Isolated from the living organism and artificially maintained, as
in a test tube.
In vivo -- Occurring within the living organism.
Lethal Concentration(Lo) (LCLo) -- The lowest concentration of a chemical in
air which has been reported to have caused death in humans or animals.
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in
air to which exposure for a specific length of time is expected to cause death
in 50% of a defined experimental animal population.
Lethal Dose(Lo) (LDLo) -- The lowest dose of a chemical introduced by a route
other than inhalation that is expected to have caused death in humans or
animals.
Lethal Dose(50)(LD50) -- The dose of a chemical which has been calculated to
cause death in 50% of a defined experimental animal population.
Lethal Time(50) (LT50) -- A calculated period of time within which a specific
concentration of a chemical is expected to cause death in 50% of a defined
experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in
a study, or group of studies, that produces statistically or biologically
significant increases in frequency or severity of adverse effects between the
exposed population and its appropriate control.
Malformations -- Permanent structural changes that may adversely affect
survival, development, or function.
Minimal Risk Level -- An estimate of daily human exposure to a chemical that
is likely to be without an appreciable risk of deleterious effects
(noncancerous) over a specified duration of exposure.
Mutagen -- A substance that causes mutations. A mutation is a change in the
genetic material in a body cell. Mutations can lead to birth defects,
miscarriages, or cancer.
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Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers
can be exposed for up to 15 min continually. No more than four excursions are
allowed per day, and there must be at least 60 min between exposure periods.
The daily TLV-TWA may not be exceeded.
Target Organ Toxicity -- This term covers a broad range of adverse effects on
target organs or physiological systems (e.g., renal, cardiovascular) extending
from those arising through a single limited exposure to those assumed over a
lifetime of exposure to a chemical.
Teratogen -- A chemical that causes structural defects that affect the
development of an organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most
workers can be exposed without adverse effect. The TLV may be expressed as a
TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged
over a normal 8-hour workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route
other than inhalation, which is expected to cause a specific toxic effect in
50% of a defined experimental animal population.
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
from experimental data. UFs are intended to account for (1) the variation in
sensitivity among the members of the human population, (2) the uncertainty in
extrapolating animal data to the case of human, (3) the uncertainty in
extrapolating from data obtained in a study that is of less than lifetime
exposure, and (4) the uncertainty in using LOAEL data rather than NOAEL data.
Usually each of these factors is set equal to 10.
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USER'S GUIDE
Chapter 1
Public Health Statement
This chapter of the profile is a health effects summary written in nontechnical
language. Its intended audience is the general public especially people living
in the vicinity of a hazardous waste site or substance release. If the Public
Health Statement were removed from the rest of the document, it would still
communicate to the lay public essential information about the substance.
The major headings in the Public Health Statement are useful to find specific
topics of concern. The topics are written in a question and answer format. The
answer to each question includes a sentence that will direct the reader to
chapters in the profile that will provide more information on the given topic.
Chapter 2
Tables and Figures for Levels of Significant Exposure (LSE)
Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health
effects by duration of exposure and endpoint and to illustrate graphically levels
of exposure associated with those effects. All entries in these tables and
figures represent studies that provide reliable, quantitative estimates of
No-Observed-Adverse-Effect Levels (NOAELs), Lowest-Observed- Adverse-Effect
Levels (LOAELs) for Less Serious and Serious health effects, or Cancer Effect
Levels (CELs). In addition, these tables and figures illustrate differences in
response by species, Minimal Risk Levels (MRLs) to humans for noncancer end
points, and EPA's estimated range associated with an upper-bound individual
lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. The LSE tables and
figures can be used for a quick review of the health effects and to locate data
for a specific exposure scenario. The LSE tables and figures should always be
used in conjunction with the text.
The legends presented below demonstrate the application of these tables and
figures. A representative example of LSE Table 2-1 and Figure 2-1 are shown.
The numbers in the left column of the legends correspond to the numbers in the
example table and figure.
LEGEND
See LSE Table 2-l
(1). Route of Exposure One of the first considerations when reviewing the
     toxicity of a substance using these tables and figures should be the
      relevant and appropriate route of exposure. When sufficient data exist,
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three LSE tables and two LSE figures are presented in the document. The
three LSE tables present data on the three principal routes of exposure,
i.e., inhalation, oral, and dermal (LSE Table 2-1, 2-2, and 2-3,
respectively). LSE figures are limited to the inhalation (LSE Figure 2-l)
and oral (LSE Figure 2-2) routes.
(2). Exposure Duration Three exposure periods: acute (14 days or less);
intermediate (15 to 364 days); and chronic (365 days or more) are
presented within each route of exposure. In this example, an inhalation
study of intermediate duration exposure is reported.
(3).  Health Effect The major categories of health effects included in
LSE tables and figures are death, systemic, immunological,
neurological, developmental, reproductive, and cancer. NOAELs and
LOAELs can be reported in the tables and figures for all effects but
cancer. Systemic effects are further defined in the "System" column
of the LSE table.
(4).  Key to Figure Each key number in the LSE table links study information
to one or more data points using the same key number in the corresponding
LSE figure. In this example, the study represented by key number 18 has
been used to define a NOAEL and a Less Serious LOAEL (also see the two
'18r" data points in Figure 2-l).
(5).  Species The test species, whether animal or human, are identified in this
      column.
(6).  Exposure Frequency/Duration The duration of the study and the weekly and
daily exposure regimen are provided in this column. This permits
comparison of NOAELs and LOAELs from different studies. In this case (key
number 18), rats were exposed to [substance x] via inhalation for 13
weeks, 5 days per week, for 6 hours per day.
(7).  System This column further defines the systemic effects. These systems
include: respiratory, cardiovascular, gastrointestinal, hematological,
musculoskeletal, hepatic, renal, and dermal/ocular. "Other" refers to any
systemic effect (e.g., a decrease in body weight) not covered in these
systems. In the example of key number 18, one systemic effect
(respiratory) was investigated in this study.
(8).  NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure
level at which no harmful effects were seen in the organ system studied.
Key number 18 reports a NOAEL of 3 ppm for the respiratory system which
was used to derive an intermediate exposure, inhalation MRL of 0.005 ppm
(see footnote "c").
(9).  LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest
exposure Level used in the study that caused a harmful health effect.
LOAELs have been classified into "Less Serious" and "Serious" effects.
These distinctions help readers identify the levels of exposure at which
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adverse health effects first appear and the gradation of effects with
increasing dose. A brief description of the specific end point used to
quantify the adverse effect accompanies the LOAEL. The "Less Serious"
respiratory effect reported in key number 18 (hyperplasia) occurred at a
LOAEL of 10 ppm.
(10). Reference The complete reference citation is given in Chapter 8 of the
      profile.
(11). CEL A Cancer Effect Level (CEL) is the lowest exposure level associated
with the onset of carcinogenesis in experimental or epidemiological
studies. CELs are always considered serious effects. The LSE tables and
figures do not contain NOAELs for cancer, but the text may report doses
which did not cause a measurable increase in cancer.
(12). Footnotes Explanations of abbreviations or reference notes for data in
the LSE tables are found in the footnotes. Footnote "c" indicates the
NOAEL of 3 ppm in key number 18 was used to derive an MRL of 0.005 ppm.
LEGEND
See LSE Figure 2-1
LSE figures graphically illustrate the data presented in the corresponding LSE
tables. Figures help the reader quickly compare health effects according to
exposure levels for particular exposure duration.
(13). Exposure Duration The same exposure periods appear as in the LSE table.
In this example, health effects observed within the intermediate and
chronic exposure periods are illustrated.
(14).  Health Effect These are the categories of health effects for which
reliable quantitative data exist. The same health effects appear in the
LSE table.
(15). Levels Of Exposure Exposure levels for each health effect in the LSE
tables are graphically displayed in the LSE figures. Exposure levels are
reported on the log scale "y" axis. Inhalation exposure is reported in
mg/m3 or ppm and oral exposure is reported in mg/kg/day.
(16). NOAEL In this example, 18r NOAEL is the critical end point for which an
intermediate inhalation exposure MRL is based. As you can see from the
LSE figure key, the open-circle symbol indicates a NOAEL for the test
species (rat). The key number 18 corresponds to the entry in the LSE
table. The dashed descending arrow indicates the extrapolation from the
exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005
ppm (see footnote "b" in the LSE table).
(17). CEL Key number 38r is one of three studies for which Cancer Effect Levels
(CELs) were derived. The diamond symbol refers to a CEL for the test
species (rat). The number 38 corresponds to the entry in the LSE table.
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(18). Estimated Upper-Bound Human Cancer Risk Levels This is the range
associated with the upper-bound for lifetime cancer risk of 1 in 10,000
to 1 in10,000,000. These risk levels are derived from EPA's Human Health
Assessment Group's upper-bound estimates of the slope of the cancer dose
response curve at low dose levels (q1*).
(19). Key to LSE Figure The Key explains the abbreviations and symbols used in
      the figure.
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Chapter 2 (Section 2.4)
Relevance to Public Health
The Relevance to Public Health section provides a health effects summary based
on evaluations of existing toxicological, epidemiological, and toxicokinetic
information. This summary is designed to present interpretive, weight-of-evidence
discussions for human health end points by addressing the following questions.
1. What effects are known to occur in humans?
2 . What effects observed in animals are likely to be of concern to
humans?
3 . What exposure conditions are likely to be of concern to humans,
especially around hazardous waste sites?
The section discusses health effects by end point. Human data are presented
first, then animal data. Both are organized by route of exposure (inhalation,
oral, and dermal) and by duration (acute, intermediate, and chronic). In vitro
data and data from parenteral routes (intramuscular, intravenous, subcutaneous,
etc.) are also considered in this section. If data are located in the
scientific literature, a table of genotoxicity information is included.
The carcinogenic potential of the profiled substance is qualitatively evaluated,
when appropriate, using existing toxicokinetic, genotoxic, and carcinogenic data.
ATSDR does not currently assess cancer potency or perform cancer risk
assessments. MRLs for noncancer end points if derived, and the end points from
which they were derived are indicated and discussed in the appropriate
section(s).
Limitations to existing scientific literature that prevent a satisfactory
evaluation of the relevance to public health are identified in the Identification
of Data Needs section.
Interpretation of Minimal Risk Levels
Where sufficient toxicologic information was available, MRLs were derived. MRLs
are specific for route (inhalation or oral) and duration (acute, intermediate,
or chronic) of exposure. Ideally, MRLs can be derived from all six exposure
scenarios (e.g., Inhalation - acute, -intermediate, -chronic; Oral - acute, -
intermediate, - chronic). These MRLs are not meant to support regulatory action,
but to aquaint health professionals with exposure levels at which adverse health
effects are not expected to occur in humans. They should help physicians and
public health officials determine the safety of a community living near a
substance emission, given the concentration of a contaminant in air or the
estimated daily dose received via food or water. MRLs are based largely on
toxicological studies in animals and on reports of human occupational exposure.
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MRL users should be familiar with the toxicological information on which the
number is based. Section 2.4, "Relevance to Public Health," contains basic
information known about the substance. Other sections such as 2.6, "Interactions
with Other Chemicals" and 2.7, "Populations that are Unusually Susceptible"
provide important supplemental information.
MRL users should also understand the MRL derivation methodology. MRLs are
derived using a modified version of the risk assessment methodology used by the
Environmental Protection Agency (EPA) (Barnes and Dourson, 1988; EPA 1989a) to
derive reference doses (RfDs) for lifetime exposure.
To derive an MRL, ATSDR generally selects the end point which, in its best
judgement, represents the most sensitive human health effect for a given exposure
route and duration. ATSDR cannot make this judgement or derive an MRL unless
information (quantitative or qualitative) is available for all potential effects
(e.g., systemic, neurological, and developmental). In order to compare NOAELs
and LOAELs for specific end points, all inhalation exposure levels are adjusted
for 24hr exposures and all intermittent exposures for inhalation and oral routes
of intermediate and chronic duration are adjusted for continous exposure (i.e.,
7 days/week). If the information and reliable quantitative data on the chosen
end point are available, ATSDR derives an MRL using the most sensitive species
(when information from multiple species is available) with the highest NOAEL that
does not exceed any adverse effect levels. The NOAEL is the most suitable end
point for deriving an MRL. When a NOAEL is not available, a Less Serious LOAEL
can be used to derive an MRL, and an uncertainty factor (UF) of 10 is employed.
MRLs are not derived from Serious LOAELs. Additional uncertainty factors of 10
each are used for human variability to protect sensitive subpopulations (people
who are most susceptible to the health effects caused by the substance) and for
interspecies variability (extrapolation from animals to humans). In deriving an
MRL, these individual uncertainty factors are multiplied together. The product
is then divided into the adjusted inhalation concentration or oral dosage
selected from the study. Uncertainty factors used in developing a
substance-specific MRL are provided in the footnotes of the LSE Tables.
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PEER REVIEW
A peer review panel was assembled for 1,2,3-trichloropropane. The panel
consisted of the following members: Dr. Hugh Farber, Private Consultant,
Midland, MI; Dr. I.G. Sipes, Professor and Head, Department of Toxicology,
University of Arizona, Tucson, AZ; and Dr. Shane Que Hee, Associate Professor,
School of Public Health, University of California, Los Angeles, CA. These
experts collectively have knowledge of 1,2,3-trichloropropane's physical and
chemical properties, toxicokinetics, key health end points, mechanisms of
action, human and animal exposure, and quantification of risk to humans. All
reviewers were selected in conformity with the conditions for peer review
specified in the Comprehensive Environmental Response, Compensation, and
Liability Act of 1986, Section 104.
Scientists from the Agency for Toxic Substances and Disease Registry
(ATSDR) have reviewed the peer reviewers' comments and determined which
comments will be included in the profile. A listing of the peer reviewers'
comments not incorporated in the profile, with a brief explanation of the
rationale for their exclusion, exists as part of the administrative record for
this compound. A list of databases reviewed and a list of unpublished
documents cited are also included in the administrative record.
The citation of the peer review panel should not be understood to imply
its approval of the profile's final content. The responsibility for the
content of this profile lies with the ATSDR.
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